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ABSTRACT 
 
JENNIFER LAURENCE MCGINNIS: Towards Understanding RNA Structure In Vivo: 
Studies on ribosomal structure and dynamics 
(Under the direction of Kevin M. Weeks) 
 
 
RNA molecules play essential roles in diverse cellular functions.  Most of these 
functions depend on the ability of the RNA to fold into a stable structure. In the cell, 
endogenous RNAs likely adopt many intermediate structures before the final functional 
structure is formed.  These structural changes occur in an environment very different from 
that of most in vitro explorations of RNA structure-function relationships.  For example,  the 
ribosome is a dynamic ribonucleoprotein responsible for synthesizing all the proteins in cells.  
Ribosomal RNA (rRNA) has been implicated in plying a crucial role in the structural, 
catalytic, and dynamic aspects of translation. Therefore, it is critical to be able to directly 
probe RNA structure in its native environment, the cell.  RNA SHAPE technology provides 
accurate and quantitative RNA structure information and is ideal to being adapted to in vivo 
conditions.  In this work I first investigate the mechanism of SHAPE so that we have a better 
understanding of this important technology.  I then show that SHAPE technology can be used 
to probe RNA structure in vivo.  I then use this new technology to obtain structural 
information for over 1400 16S nucleotides in many conformational states of the 16S rRNA in 
vivo.   In many regions, the in vivo SHAPE chemistry is exactly consistent with in vitro RNA 
structure studies.  However, in several key areas, the in vivo rRNA structure differs from that 
of its in vitro counterpart.  Local, but highly significant, rearrangements in the RNA 
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secondary structure thus appear to contribute to ribosome function in vivo. As further 
evidence that investigating RNA structure in vivo is necessary for our fundamental 
understanding of biology, I use in vivo SHAPE to identify a novel secondary mode of action 
for an antibiotic.  This work illustrates that a full understanding of dynamic RNA structure at 
nucleotide resolution will be critical for complete understanding of RNA function in vivo. 
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 CHAPTER 1 
Importance of probing RNA structure in vivo 
 
1.1 Introduction 
1.1.1 RNA structure and function 
Long thought to be a passive conduit for converting genetic information stored in the 
DNA into proteins, we now know that RNA plays an essential role in diverse cellular 
functions such as protein synthesis, gene regulation, and catalysis (1).  Nearly all of these 
functions depend on the ability of the RNA to correctly fold into one or more specific 
structures.  Although only composed of 4 main building blocks, RNAs can fold into multiple 
stable conformations, even though only one might be the functional state.  In vivo, RNA 
structure, and thus its function, is often influenced through the direct binding of proteins, 
large and small ligands, small molecules, and ions. More often than not, the cellular 
processes depend on an RNA to be dynamic, that is changing conformation in a specific, 
biologically relevant manner.   Thus, an important first step in understanding the function of 
an RNA is determining its structure. 
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1.2 RNA structure in vivo 
 In the cell, endogenous RNAs fold co-transcriptionally, and likely adopt many 
intermediate structures before the final functional structure is formed (2-4).  These structural 
changes occur in an environment very different from that of most in vitro explorations of 
RNA structure-function relationships.  The complex cellular environment is impossible to 
perfectly mimic in in vitro studies.  We often use high ion concentration and heat to influence 
structure equilibriums (4).  However, this is a poor mimic for in vivo conditions as it is non-
specific.  Recently the intracellular Mg2+ concentration has been measured at 1 mM Mg2+ 
(Tyrell et. al unpublished results).  However most RNA structure-function experiments are 
performed at 10X that amount (3).  One of the main problems with this is that although 
addition of magnesium will stabilize an RNA fold, it will do so rather indiscriminately, 
whereas in vivo, many RNAs associate with proteins and other cofactors to stabilize the 
structure in a very specific manner (5).  Thus developing techniques to assess RNA structure 
in live cells is critical to understanding RNA processes.  
 
1.3  RNA SHAPE chemistry 
Selective 2!-hydroxyl acylation analyzed by primer extension (SHAPE) is a robust 
tool for probing structure-function interrealationships in RNA (6).  SHAPE takes advantage 
of the discovery that the reactivity of the 2!-hydroxyl position is highly sensitive to local 
nucleotide flexibility (7, 8).  Flexible nucleotides sample many conformations, a few of 
which preferentially react with hydroxyl-selective electrophilic reagents to form 2!-O-adducts 
(9) (Figure 1.1A). The adducts are then detected by primer extension (Figure 1.1B).  Since 
SHAPE reagents react with all four nucleotides (10), quantitative information about local 
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nucleotide flexibility can be obtained simultaneously at almost all positions in an RNA in a 
single experiment.  In Chapter 2, I describe my work identifying the nucleotide 
conformations that are preferentially reactive towards SHAPE and the elucidation of the 
mechanisms of SHAPE. 
 
1.3.1 SHAPE chemistry is ideal for probing RNA structure in vivo 
SHAPE chemistry possesses several features that make it ideal for probing RNA 
structure in vivo. The reagents used for modification, like 1-methly-7-nitro-isatoic anhydride 
(1M7), are small and hydrophobic, so these molecules should readily cross the cellular 
membrane to modify RNA structures inside the cell.  The reagents are also self-quenching 
(Figure 3.1A), which simplifies the experiment and is less disruptive to the cellular 
environment.  Conditions used during SHAPE modification result in ~1 modification every 
300 nucleotides, so these adducts should be less disruptive to the RNA structure compared 
with other chemical probes such as DMS.  Primer extension, is by nature, RNA-specific, so 
careful design of primers allows detection of only the RNA of interest.  In Chapter 3, I 
confirm that SHAPE chemistry is able to modify RNA structure in a structure-selective 
manner.  Additionally, it reports a 2-minute structural snapshot of the RNA in vivo. I then use 
SHAPE in vivo to probe the steady-state structure of the 16S rRNA.  
 
1.4 Challenges of probing RNA structure in vivo 
In some ways the1542-nucleotide 16S ribosomal RNA represents an ideal RNA to 
study in vivo. First, rRNA makes up 80% of total RNA in the cell (11). Second, 16S rRNA 
has been well-characterized in vitro using biochemical and crystallographic techniques (12-
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14).  Third, although the 70S ribosome, and specifically the 16S rRNA, has been studied 
intensively in vitro, little is known about 16S rRNA structure in vivo.  However, it also 
epitomizes the difficulties of in vivo RNA structure analysis.  First, it is large, requiring 5-6 
primers to completely analyze the 16S rRNA in one state. Second, in the cell, the 16S rRNA 
exists in a variety of conformational states and is very dynamic.  One of the largest obstacles 
to using chemical probing methods in vivo is the difficulty in analyzing dynamic RNA 
structure.  Since in solution probing yields a reactivity profile that is the sum of the reactivity 
profile of any of the structures found in the population during incubation time, the most 
abundant structure will contribute most to the reactivity pattern.  In Chapter 4, I take an 
important step towards solving this issue by showing that SHAPE chemistry can be 
combined with sucrose gradient sedimentation to allow separate analysis of the different 
ribosomal particles in vivo. 
 
1.5 The Ribosome  
The ribosome is a large macromolecular complex responsible for protein synthesis in 
all living cells.  Typically composed of 60% RNA and 40% protein, it catalyzes peptide bond 
formation according to an mRNA template in a highly accurate, fast, and dynamic process 
known as translation. Translation requires repeated cycles of concerted movement of tRNA, 
mRNA, and nascent peptide chain through the ribosome (15) with each tRNA traversing over 
130 Å from initial binding to exiting the ribosome(16, 17). 
The bacterial ribosome is composed of two subunits, the 50S and the 30S, which bind 
to form the functional 70S complex (Figure 1.#). The 50S subunit binds the 3' ends of the 
tRNAs, contains the peptidyl transferase center, and has binding sites for elongation factors 
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(17). The 30S subunit, containing 16S rRNA and 21 proteins binds the mRNA and the tRNA 
anticodon stem-loops (18).  It is responsible for monitoring the fidelity of translation (19).   
Ribosomal RNA (rRNA) plays a crucial role in both catalytic and dynamic aspects of 
translation (20, 21).   
 
1.5.1 The 16S secondary structure: a static model for a dynamic RNA 
The secondary structure model of the 16S rRNA derived from covariation analysis 
(22) is shown in Figure 1.3A.  It is made up of 45 helices (h1-h45) and can be organized into 
four distinct structural domains: the 5!, central, 3! major and minor domains.  These domains 
fold into the morphological features of the 30S subunit observed from electron microscopy 
and x-ray crystal structures(23).  The 5! domain makes up the body; the central domain forms 
the bulk of the platform; the 3! major domain constitutes the bulk of the head and the 3! 
minor domain spans the intersubunit surface of the 30S body (Figure 1.3B).  The domains are 
directly connected in the secondary structure through the central pseudoknot. Upon 
visualizing the secondary structure, it is important to note that this representation depicts a 
very static structure, but the 16S rRNA is very dynamic.   
In the cell, the 16S rRNA undergoes a series of complex events during its “lifetime”: 
The RNA is must be transcribed, processed to the mature full-length form, and certain 
nucleotides modified; concurrently, it folds back on itself, associating with ribosomal 
proteins to form the 30S subunit. Much of 30S assembly is unknown in terms of the RNA 
structure.  Upon association with initiation factors and the 50S subunit, the 16S rRNA 
becomes part of the 70S ribosome. This large complex associates with elongation factors, 
tRNA, and mRNA during elongation to translate messenger RNA (mRNA) into a 
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polypeptide sequence.  Upon finishing translating the mRNA, it then associates with 
recycling factors and is ready to begin another round of translation. Finally, the ribosome is 
disassembled and the RNA is degraded (24, 25).  It seems unlikely that the 16S rRNA 
exhibits the same secondary structure formation during all of these events..  In chapters 3,4, 
and 5, I identify possible RNA secondary structural changes that occur in vivo.   
 
1.6  Research Overview 
 The overall goal of my project is to advance our understanding of RNA structure in 
vivo through developing SHAPE technology as a facile way to probe RNA structure in live 
cells.   I do this primarily through investigation of the structural dynamics of the 16S rRNA. 
 I show that SHAPE can be used to study RNA structure in vivo.  Additionally, I show 
that the 16S rRNA exists in a variety of conformations in the cell, that are not always 
observed in vitro.  It is my hope that the development of SHAPE as an in vivo technology 
and the data presented here will encourage other scientists to investigate RNA structure in 
vivo. 
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Figure 1.1  RNA SHAPE Chemistry is a two step process (A) Selective 2’-hydroxyl 
acylation forms a 2’-O-adduct at flexible nucleotides (B) Primer extension detects SHAPE 
2’-O-adduct formation 
O O
O
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Figure 1.2  Crystal structure of the bacterial ribosome (A) The whole 70S ribosome 
modeling the A- (yellow), P- (orange), and E-site (red) tRNAs. The large subunit 23S rRNA 
is shown in grey. The small subunit 16S rRNA is shown in cyan. Ribosomal proteins are 
shown in purple (B) Open book view of the 30S subunit (left) and 50S subunit (right). (Pdb 
file: 2J02, 2J03, 1EHZ; (21). 
70S complex
30S subunit 50S subunit
30S subunit 50S subunit
A
P
E
16S
E
P
A
23S
A
B
5S
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Figure 1.3 Structure of the E. coli 16S rRNA (a) The secondary structure model as 
determined by covariation (22), the central pseudoknot is boxed (b) and tertiary structure (b) 
(Pdb file: 2AVY (26).  The 5!domain, central domain, 3! major domain, and 3! minor domain 
are colored green, grey, magenta, and cyan, respectively.  The major 30S morphological 
features are pointed out.  30S proteins are shown in dark purple. 
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CHAPTER 2 
The Mechanisms of RNA SHAPE Chemistry 
 
2.1 Introduction 
The functions of almost all RNAs are governed or tuned by the base-paired secondary 
structure and higher-order tertiary interactions.  Understanding the information expressed in 
RNA structure thus requires accurate and comprehensive knowledge about the local 
environment of most nucleotides in an RNA. Selective 2!-hydroxyl acylation analyzed by 
primer extension (SHAPE) chemistry provides comprehensive information on local 
nucleotide dynamics and has proven useful in probing structure-function interrelationships in 
RNA,(1) RNA-protein interactions,(2, 3) RNA-small molecule interactions,(4-6) and RNA 
folding dynamics.(7, 8) Because the nucleotide dynamics monitored by SHAPE correlate 
inversely with the likelihood that a nucleotide is constrained by base pairing, SHAPE data 
increase the accuracy of RNA secondary structure prediction.(9-12)  SHAPE has facilitated 
development of functional hypotheses in complex biological systems.(13-17) Innovative 
refinements and applications of SHAPE include time-resolved(7, 8, 18, 19) and temperature-
dependent analyses,(5, 20) examination of short RNAs(21, 22) and interfacing with new 
readout technologies,(23) detection of long-range through-space interactions,(2, 24-27) and 
identification of optimal sites for attachment of fluorescent reporter probes.(28)  
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SHAPE reagents are small-molecule electrophiles like 1-methyl-7-nitroisatoic 
anhydride (1M7)(29) and benzoyl cyanide (BzCN)(18) that react preferentially with the 2!-
hydroxyl group of flexible nucleotides to form a 2!-O-adduct (Figure 2.1). The sites at which 
these adducts form are detected by either primer extension or by protection from 
exoribonuclease digestion. SHAPE provides a quantitative measure of local nucleotide 
order,(30) interrogates all four nucleotides in a single experiment,(31) and works well in 
diverse solution conditions and biological environments.(14, 32, 33)  
The reactivity of the RNA 2'-ribose position is exquisitely sensitive to the nucleotide 
conformation.(34, 35) The mechanism that best explains the quantitative sensitivity of 
SHAPE to local nucleotide flexibility is that flexible nucleotides sample multiple 
conformations, and a small number of these conformations enhance the reactivity of the 2!-
hydroxyl group towards SHAPE electrophiles (Figure 2.1).  Neither the nature of these 
reactive conformations nor mechanisms by which they enhance 2'-OH reactivity are fully 
understood.  
If SHAPE is primarily governed by the ability of a given nucleotide to sample rare 
conformations that enhance 2'-OH reactivity, then there must exist a few nucleotides that are 
constrained in conformations poised for efficient reaction at the 2!-hydroxyl group.  An 
important first step towards understanding the mechanism of SHAPE was the observation 
that cyclic adenosine monophosphate (cAMP) is 10-18 fold more reactive towards SHAPE 
reagents than are nucleotides in single-stranded RNA.(35) In the fixed conformation of 
cAMP, the 3!-phosphodiester is constrained in a 3',5' cyclic linkage.  The observed "hyper-
reactivity" of cAMP is consistent with a model in which close proximity of the negatively 
charged internucleotide phosphodiester group destabilizes 2!-oxyanion formation during 2'-
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O-adduct synthesis.  It is unlikely, however, that this is the only conformation that enhances 
the nucleophilicity of the 2!-hydroxyl.  
To identify nucleotide conformations that are reactive towards SHAPE, we performed 
SHAPE on the 16S ribosomal RNA (rRNA) in intact crystals of the E. coli ribosome.(36) We 
identified nucleotides that were hyper-reactive relative to the standard SHAPE reactivity 
scale and that also had well-defined experimental electron density.  These nucleotides cluster 
into a small number of conformations that must facilitate the nucleophilic reactivity of the 2!-
hydroxyl towards SHAPE reagents.  We explored the mechanisms of these enhancements 
using a series of nucleotide analogues and showed that 2!-hydroxyl reactivity is enhanced by 
general base catalysis involving multiple RNA functional group partners and by two specific 
orientations of the 3!-phosphodiester backbone. These results support specific mechanisms 
for SHAPE reactivity and will facilitate interpretation of SHAPE reactivities in the many 
technologies that are now making use of this chemistry. 
 
2.2 Results  
2.2.1  In-crystal SHAPE reveals hyper-reactive nucleotides. 
The 1542-nucleotide 16S rRNA in crystals of E. coli 70S ribosomes represents an 
ideal system to discover the conformations of nucleotides reactive towards SHAPE. First, in 
the crystal, 16S rRNA is in a static, constrained state; second, individual nucleotides are in 
diverse conformations; and, third, structural information on nucleotide geometries exists at 
sufficiently high resolution (3.2 Å) to support development of concrete, testable hypotheses. 
Crystals used in SHAPE analyses were essentially identical to those used in previous 
high-resolution structural studies.(36) Before SHAPE probing, the crystals were washed 
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extensively to remove uncrystallized ribosomes.  The RNA in the crystals was modified by 
the addition of 1M7 at 4 °C. After washing to remove ribosomes that might have dissolved as 
a result of the modification reaction, the RNA was isolated by standard approaches and sites 
of SHAPE modification were identified by primer extension followed by capillary 
electrophoresis.(10, 37, 38) 
This analysis yielded a SHAPE reactivity profile for ~1490 of the 1542 nucleotides in 
the 16S rRNA (Figure 2.2A).  Nucleotide reactivities were normalized to a scale in which 
unreactive nucleotides had zero reactivity and the mean reactivity of the reactive nucleotides 
was defined as 1.0.  On this scale, reactivities for the vast majority of the nucleotides 
analyzed fell in a range from zero to 1.5. However, 35 nucleotides had SHAPE reactivities in 
the range of 2 to 10 (in purple, Figure 2.2A). These hyper-reactive nucleotides presumably 
adopt conformations that activate the 2'-OH group for the SHAPE reaction. The crystals 
contain two copies of the ribosome and we focused on the more highly ordered of these (see 
Methods for additional discussion). In the more ordered ribosome, 17 of the 35 hyper-
reactive nucleotides had weak electron density in the crystal structure (Figure 2.2B, 
nucleotide 412) and 18 were well defined by the experimental electron density (Figure 2.2B, 
nucleotide 422). 
 
2.2.2  SHAPE reactivities are not governed by solvent or molecular accessibility. 
Although all evidence to date suggests that solvent accessibility does not strongly 
influence SHAPE reactivity,(1) the in-crystal reactivity profile provided a unique opportunity 
to evaluate this relationship on a large data set. We compared SHAPE reactivities with the 
accessibility of the ribose 2!-hydroxyl group as a function of spherical probes ranging from 
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1.4 Å to 7.0 Å. The correlation between reactivity and solvent accessibility was low both for 
a probe size of 1.4 Å (r = 0.20) corresponding to water and for one of 6.0 Å (r = 0.15), which 
reflects the approximate molecular diameter of 1M7 (Figure 2.3).  In addition, one-half of the 
hyper-reactive nucleotides with well-defined conformations (9 of the 18) had low solvent 
accessibilities, less than 8 Å2, at the 2'-hydroxyl position. As many nucleotides with very low 
solvent and molecular accessibilities reacted readily with 1M7, SHAPE is essentially 
insensitive to solvent accessibility. 
 
2.2.3 Structural families for hyper-reactive nucleotides 
We grouped the 18 hyper-reactive nucleotides with well-defined conformations in the 
crystal by structural features, including ribose pucker, distance between 2'-OH and adjacent 
3'-phosphodiester, and the presence of a nearby functional or catalytic group. Both the 
standard C3'-endo and the rarer C2'-endo conformation were represented with 7 and 11 
examples, respectively (emphasized in yellow and cyan, Figure 2.4).  Given that nucleotides 
in the C3'-endo conformation occur roughly ten times more frequently in RNA than those in 
the C2'-endo conformation,(39) the C2'-endo conformation is highly over-represented among 
hyper-reactive nucleotides, a feature noted previously (32). 
The orientation of the 3!-phosphodiester relative to the 2!-OH group was evaluated in 
two ways: (i) as the distance between the 2!-OH and a vector corresponding to the sum of the 
two phosphorus to non-bridging oxygen bond vectors (see PO-to-2'-OH distance, Figure 
2.6A, top) and (ii) as the distance between the 2!-OH and the closest non-bridging phosphate 
oxygen. Orientations of the 3'-phosphodiester group fell into two distinct conformations. Five 
nucleotides had orientations in which the non-bridging oxygen groups of the 3'-
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phosphodiester were oriented away from the 2'-OH group and thus the PO-to-2'-OH distance 
was relatively long at ~5.5 Å (Figure 2.4, left-hand circle). Of these, four were in the C3'-
endo conformation and closely resembled the conformation of cAMP (Figure 2.4, upper left). 
This observation supports the model(35) that electrostatic communication between the 3'-
phosphodiester and the 2'-OH strongly modulates reactivity of the 2'-hydroxyl group. It is 
also possible for nucleotides in the C2'-endo conformation to have a long distance between 
the 3'-phosphodiester and the 2'-OH group; we observed one example in our study (Figure 
2.4, nucleotide A1257). There were ten examples of the conformation in which one of the 
non-bridging oxygen groups was within ~3.4 Å of the 2'-OH (Figure 2.4, right-hand circle).  
In this case, the non-bridging oxygen likely facilitates SHAPE reactivity by functioning as a 
general base. 
Six nucleotides adopt a conformation that brings the 2'-hydroxyl group within, or 
very close to, hydrogen bonding distance of oxygen or nitrogen functional groups with 
available lone pairs and that might also function as general bases (Figure 2.4, center circle). 
In five of these nucleotides, hydrogen bonding between the 2'-OH and the base O2 group of 
cytosine or uridine was possible, whereas hydrogen bonding with the N3 group of adenosine 
was possible in one case (A1257). In three examples, the 2'-OH was within 4.2 Å of 
hydrogen bond acceptors involving non-adjacent nucleotides, suggesting that SHAPE 
reactivity might be facilitated by long-range, through-space interactions (Figure 2.5). Of the 
18 hyper-reactive nucleotides, only one, A243, did not fit into any of these conformational 
categories, and the reason for its hyper-reactivity is not understood. 
2.2.4 Hyper-reactive nucleotides have unusual conformations 
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We next evaluated how common the identified conformations are by comparing the 
geometric parameters of the three classes of hyper-reactive nucleotides to all single-stranded 
nucleotides in the 16S rRNA with well-defined electron densities (182 nts total).  Data are 
summarized using box plots (Figure 6) in which the rectangle spans the central 50% of the 
data, or the interquartile range (IQR), and the median is shown in a heavy line.  Extreme 
values, greater than 1.5 times the IQR, are shown explicitly as circle or square symbols. The 
distribution of PO-to-2'-OH distances (Figure 2.6A) for the hyper-reactive nucleotides is 
notably different from that of all single-stranded nucleotides in the 16S rRNA and is distinct 
for pyrimidine and purine nucleotides. Of the 17 hyper-reactive nucleotides, only one fell 
into the IQR that characterized most single-stranded nucleotides in 16S rRNA. Five hyper-
reactive nucleotides are characterized by a long PO-to-2'-OH distance, possible only when 
the 3'-phosphodiester points away from the 2'-OH group (Figure 2.6A, top). The remaining 
12 hyper-reactive nucleotides showed shorter than median PO-to-2'-OH distances, consistent 
with a hydrogen-bonding interaction. 
The distribution of distances between the 2!-OH group and the pyrimidine O2 or 
purine N3 positions is also notably distinct from mean distances between the O2 or N3 
position and all 2'-hydroxyl groups in single-stranded nucleotides in the 16S rRNA (Figures 
2.6B and C, respectively). Six of the hyper-reactive pyrimidine nucleotides had much shorter 
distances between the 2!-OH and the base O2 position than characterized most nucleotides in 
the16S rRNA. The distribution among the purine nucleotides was distinct both from single-
stranded 16S rRNA nucleotides and from the hyper-reactive pyrimidines. One hyper-reactive 
purine nucleotide had a short distance between the 2!-hydroxyl and the N3 positions, whereas 
most of hyper-reactive purine nucleotides had longer than typical distances. These 
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observations suggest that the most favorable conformations that facilitate 2'-OH reactivity 
may be different for pyrimidine and purine nucleotides but, in both cases, enhanced reactivity 
is strongly favored by an unusual nucleotide conformation. 
2.2.5  Functional group substitution supports general base catalysis 
To test the hypothesis that specific RNA functional groups – especially the non-
bridging phosphate oxygen and the pyrimidine O2 group – enhance the nucleophilic 
reactivity of the 2'-hydroxyl, we evaluated the effect of substituting individual functional 
groups in the context of a model RNA hairpin with a GNRA tetraloop and a single bulged 
nucleotide of either A or U. Two nucleotides flanking the 5' and 3' sides of the stem were 
designed to remain unpaired to permit normalization of SHAPE profiles (Figure 2.7A).  In-
solution SHAPE indicated that none of the nucleotides in this RNA were hyper-reactive 
(Figure 2.7, black lines at right).  
In the context of this model, we evaluated the impact of the non-bridging oxygen 
groups from the 3'-phosphodiester by analysis of a transcript containing phosphorothioate-
substituted guanosine analogues.  In this RNA, the pro-R oxygen was replaced with sulfur at 
the 3'-phosphodiester group for three single-stranded residues (Figure 2.7A, yellow stars). In 
a standard nucleotide, the phosphate atom and non-bridging oxygens carry a net negative 
charge, whereas in the phosphorothioate analogue, the charge resides preferentially on the 
sulfur atom(40) leaving the pro-S oxygen electron deficient and a weaker hydrogen bond 
acceptor and general base (Figure 2.7B, left). SHAPE profiles for the native and 
phosphorothioate-substituted RNAs were similar, indicating that the stem-loop RNA folds 
into roughly the same structure in both RNAs. Strikingly, however, the SHAPE reactivities at 
each single-stranded nucleotide with a 3'-phosphorothioate substitution were 2-fold lower 
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than the reactivities of these nucleotides in the unmodified transcript (Figure 2.7, graph).  
The electronic distribution at the 3'-phosphodiester group thus has a significant facilitating 
effect on 2'-OH reactivity. 
The contribution of the pyrimidine O2 group to SHAPE reactivity was evaluated by 
substitution of the O2 atom with sulfur using 2-thio-uridine (Figure 2.7C).  Sulfur is a poor-
hydrogen bond acceptor due to its size and diffuse electron cloud.(41) The thiocarbonyl 
group in 2-thio-uridine thus disrupts the ability of this position to serve as a general base.  
SHAPE reactivities at U27 in the loop and at the bulged U34 in the 2-thio-uridine transcript 
decreased by 2-fold compared to reactivities of these nucleotides in the unsubstituted RNA 
(Figure 2.7C). SHAPE reactivities for the two adenosine nucleotides in the loop, adjacent to 
U27, also decreased in the 2-thio-uridine-substituted RNA relative to those in the unmodified 
transcript suggesting that substitution of the O2 position affects the reactivity of neighboring 
nucleotides.  
Finally, the contribution of the purine N3 position was tested using the nucleotide 
analogue 3-deaza-adenosine (Figure 2.7D), which substitutes carbon for nitrogen and 
eliminates the ability of the substituted nucleotide to act as a general base.  This substitution 
caused a 40% decrease in SHAPE reactivity at the bulged A relative to the position in the 
unmodified RNA but did not change the reactivity of the two adenosines in the loop. These 
data suggest the purine N3 group facilitates 2'-OH reactivity in some, but not all, structural 
contexts. 
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2.2.6 Catalysis by a solution-phase general base 
SHAPE reactivity was strongly enhanced by general base catalysis involving 
functional groups in RNA (Figures 2.4 and 2.7). An exogenous solution-phase base should 
therefore also enhance SHAPE reactivity. We monitored SHAPE reactivity of a 5'-labeled 
dinucleotide of adenosine and dideoxycytosine, which contains a single free 2!-hydroxyl that 
reacts with 1M7 to form a mono 2!-O-adduct (Figure 2.8A). SHAPE reactivity was 
monitored at constant pH as a function of added imidazole, which contains lone pair 
electrons on nitrogen and is a good general base. Pyrrole, with a similar structure but without 
non-bonded lone pairs, was used as a control. Addition of 1 M imidazole increased 2!-O-
adduct formation two fold, whereas pyrrole addition had no detectable effect on reactivity 
(Figure 2.8B). These results strongly support the hypothesis that SHAPE reactivity is 
enhanced by general base catalysis involving both intra-nucleotide and through-space 
catalytic groups. 
 
2.3 Discussion 
RNA SHAPE chemistry detects local nucleotide flexibility in a way that correlates 
closely with independent measures of molecular order in RNA(30, 35) but that is largely 
independent of solvent or molecular accessibility (Figure 2.3). SHAPE is best explained by a 
model in which reactive nucleotides preferentially sample relatively rare conformations that 
increase the nucleophilic reactivity of the 2'-OH group (Figure 2.1). The corollary to this 
model, which provides a critical segue into understanding the mechanism of SHAPE, is that 
there must exist a few nucleotides that are constrained in reactive conformations(42). 
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Thirty-five nucleotides (~2% of those examined) in the 16S rRNA in crystals of E. 
coli ribosomes proved to have unusually high reactivities when interrogated by SHAPE in 
crystallo. This prevalence of hyper-reactive nucleotides corresponds closely to that observed 
in prior studies in our laboratory.(9, 20) The conformations of 18 of these nucleotides were 
well defined by the experimental electron density. Analysis of the conformations adopted by 
these nucleotides supports two overarching models for the underlying mechanism of SHAPE 
chemistry. 
First, reactivity was enhanced by conformations in which the non-bridging oxygen 
atoms from the adjacent 3'-phosphodiester are directed away from the reactive 2'-OH group. 
This mechanism was initially characterized using cAMP,(35) which remains one of the most 
hyper-reactive nucleotides identified to date: Its reactivity is ~15 on the scale used here for 
16S rRNA (see Figures 2.2A and 2.4). The phosphodiester-away mechanism is now 
supported by five examples of hyper-reactive nucleotides in the 16S rRNA (Figure 2.4, left-
hand circle). This conformation supports 2'-OH reactivity by reducing electrostatic 
destabilization of the reactive 2'-oxyanion (δ–), and perhaps other partial charges, in the 
transition state (Figure 2.9A).  
Second, SHAPE reactivity was enhanced by a proximal functional group capable of 
forming a hydrogen bond with the 2'-OH group (Fig. 4, middle and right-hand circles). These 
hyper-reactive conformations are remarkably diverse and include those that allow 
interactions with functional groups on the nucleobases, the pro-S non-bridging phosphate 
oxygen, and through-space hydrogen bond acceptors (Figure 2.9B). In these cases, SHAPE 
reactivity is facilitated through deprotonation of the reactive 2'-OH via general base catalysis 
(equivalent to lowering the pKa of the 2'-OH group). This mechanism is strongly supported 
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by functional group substitution studies showing that reducing the electron density on these 
atoms, which limits their ability to function as general bases, had a large effect on 2'-OH 
reactivity (Figure 2.7).  
The vast majority of nucleotides (85) in the 16S rRNA crystal that exhibited high 
(0.7–2.0) SHAPE reactivities had very little electron density and are likely dynamic. Only 18 
nucleotides with high reactivities had well-defined positions in the crystal. Of these, 15 
adopted conformations consistent with our reactivity-facilitating conformations (Supporting 
Table 2.1). Thus, SHAPE reactivity mechanisms defined by evaluating hyper-reactive 
positions appear to apply broadly to RNA nucleotides. 
When general base catalysis predominates, pyrimidine and purine nucleotides may 
react via different preferred conformations. The interaction between the pyrimidine O2 and 
2'-OH appears to be especially favorable and occurred in five examples in our set of hyper-
reactive nucleotides (Figure 2.4). For purine nucleotides, it appears to be more common for a 
non-bridging phosphodiester oxygen to function as the general base rather than the 2'-OH (of 
which we have a single example). Supporting this hypothesis, substitution of the pyrimidine 
O2 atom had a larger compromising effect on SHAPE reactivity than did substitution at the 
purine N3 group (Figures 2.6C and D). 
C2'-endo nucleotides were highly over-represented among the hyper-reactive 
nucleotides, a feature noted in studies of the Tetrahymena P546 domain.(32) All examples of 
apparent intra-nucleotide general base catalysis involved nucleotides in the C2'-endo 
conformation (Figure 2.4, center circle). Our data are consistent with a model in which the 
C2'-endo conformation facilitates 2'-OH reactivity primarily because it enhances the ability 
of the 2'-OH group to interact favorably with nearby general base groups, especially with the 
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pyrimidine O2 or purine N3 atoms.  However, the C2'-endo conformation is clearly not 
required for efficient SHAPE reactivity as evidenced by the many examples of hyper-reactive 
nucleotides in the C3'-endo conformation and by the high reactivity of cAMP, which is 
constrained in a C3'-endo-like conformation. 
Finally, interactions with non-adjacent nucleotides can play a significant role in the 
nucleophilic reactivity of the 2'-OH group. First, phosphorothioate and 2-thio-uridine 
substitutions affected the reactivity of 2'-OH groups located one or two nucleotides away 
from the site of the substitution (Figures 2.6B and C). Second, in addition to local 
interactions, three 2'-OH groups among the hyper-reactive nucleotides and 11 of 18 2'-OH 
groups among highly reactive nucleotides are close to a general base group located on a non-
adjacent nucleotide in the 16S rRNA (Figure 2.5 and Table 2.1). Third, the strong facilitating 
effect of imidazole indicates that through-space interactions can significantly enhance 2'-OH 
reactivity (Figure 2.8). The net effect of all potential non-adjacent contributions provides a 
likely explanation for why SHAPE is uncorrelated with solvent accessibility (Figure 2.3). 
Any accessibility penalty born by buried nucleotides is apparently compensated for by the 
density of functional groups able to function as general base catalysts in a folded RNA. 
In sum, SHAPE reactivity at the 2'-OH group is facilitated by two major mechanisms 
(Figure 2.9), each of which can be achieved by wide variety of nucleotide conformations. All 
hyper-reactive conformations identified through our analysis are incompatible with canonical 
Watson-Crick base pairing and fall predominantly into three well-defined structure classes. 
That diverse conformations facilitate reactivity strongly reinforces the basic biophysical 
model that SHAPE measures RNA dynamics. The data reported here explain the strong 
observed correlation between SHAPE reactivity and molecular motion(30). In addition to 
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understanding SHAPE-based analyses, the specific reactivity mechanisms established here 
emphasize the broad catalytic potential of functional groups in RNA and provide mechanistic 
insight into the general reactivity of distinct RNA conformations towards chemical probes, 
epigenetic modifying agents, and mutagens. 
 
2.4 Methods 
2.4.1  SHAPE analysis of 16S rRNA in 70S crystallized ribosomes 
Crystals of the E. coli 70S ribosome were prepared as described.(36)  Ribosome 
crystals were washed three times in the same buffer used for cryo-protection and stabilization 
in the crystallographic studies, with the exception that the pH was increased from 4.8 to 6.5 
[XB: 7% 2-methyl-2,4-penanediol, 7% PEG 8000, 24% PEG 400, 3.8 mM MgCl2, 380 mM 
NH4Cl, 5.5 mM putrescine, 5 mM spermidine, 22.5 mM MES (pH 6.5)] to remove free 
ribosomes prior to SHAPE analysis. Crystals were resuspended in 36 µL XB and SHAPE 
experiments were initiated by addition of 1/10 volume 1M7 (20 mM) in DMSO. Control 
reactions contained an equivalent volume of neat DMSO. Reactions were incubated for 2.5 
hr at 4 °C (approximately 5 half lives for the hydrolysis rate of 1M7 in XB). Modified 
crystals were washed three times with XB to remove any free ribosomes, dissolved in 250 µL 
1× TE and 50 µL 0.1 M dithiothreitol, and extracted three times with 
phenol:chloroform:isoamyl alcohol (25:24:1) and two times with chloroform:isoamyl alcohol 
(24:1). Total RNA was recovered by precipitation with ethanol, and 2!-O-adducts were 
detected by primer extension.  Five primer pairs of 19-22 nucleotides were used with 3' 
positions complementary to 16S rRNA positions 323, 559, 947, 1112, and 1492.(9) Primer 
extension products were resolved on an ABI 3130 capillary electrophoresis instrument.  As 
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judged from the long extensions obtained, RNA modification to form 2'-O-adducts was 
sparse, roughly 1 in ~300 nts were modified. Raw electropherograms were analyzed using 
ShapeFinder.(37)  Positions exhibiting high background were discarded and reactivities 
slightly less than zero were reset to zero.  Three independent experiments were completed for 
each primer set and the resulting SHAPE data averaged (Figure 2.10). Data sets were 
normalized by first excluding the top 2% of reactive nucleotides and then by dividing the 
reactivity for each nucleotide by the average of the next 8% most reactive nucleotides. The 
full dataset has been deposited in the SNRNASM database.(43) 
 
2.4.2 Analysis of nucleotide geometries in 16S rRNA 
All analyses started with the well-ordered E. coli ribosome visualized in a recent 
atomic-resolution structure, pdb id 3i1m.(36)  The crystals contain two ribosomes in each 
asymmetric unit.  We focused our analysis on the better ordered (A) ribosome. For the 
nucleotides with well-defined conformations in both ribosome structures, nucleotide 
conformations were identical.  Hyper-reactivities are likely to be underestimated as they 
reflect contributions from both highly ordered and less well-ordered ribosomes. The starting 
model was initially improved using MolProbity(44) to identify all-atom clashes and suspect 
ribose sugar conformations. Corrections were carried out in Coot.(45)  Changes to the 
structure were only accepted if they survived refinement and did not compromise model 
geometry. The local conformations of nine of the well-ordered hyper-reactive nucleotides 
were ultimately adjusted (positions 250, 422, 531, 532, 701, 1278, 1297, 1336 and 1452). 
Nucleotides were initially aligned through the ribose moiety and then grouped according (i) 
to the distance between the 2!-OH and the vector bisecting the non-bridging oxygens in the 
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adjacent 3!-phosphodiester and (ii) to the presence of a nearby functional group resulting in 
three categories (Fig. 4).  One nucleotide (A243) did not fit into any of these three categories 
as determined by non-parametric box-plot analysis(46) and Dixon’s Q-test.(47)  For the box-
plot analysis (Figure 6), well-ordered single-stranded nucleotides were defined as those not 
participating in conserved Watson-Crick base pairs, according to the secondary structures 
derived by comparative sequence analysis,(42) and possessing an atomic displacement factor 
less than 60 in crystallographic refinement. 
 
2.4.3 Nucleotide triphosphate analogues and RNA stem-loop synthesis 
Phosphorothioate triphosphates and 2-thiouridine-5!-triphosphate were obtained from 
Glen Research and Trilink Biotechnologies, respectively. 3-Deaza-adenosine triphosphate 
was synthesized from 3-deaza-adenosine (Texas Biochemicals) as described.(48) DNA 
templates directing synthesis of the stem-loop RNA [5!-(U/A)(U/A)GUC ACCAG CGUAA 
GCUG(A/U) GUGAC (U/A)(U/A)-3!] embedded in 5! and 3! structure cassette 
sequences(35) were obtained by PCR. For analysis of phosphorothioate or 3-deaza-adenosine 
substitutions, the RNA contained a bulged adenosine and flanking uridine residues; for the 2-
thiouridine substitution, the RNA contained a bulged uridine and flanking adenosine residues 
(Fig. 6). RNA constructs were synthesized by in vitro transcription [0.5 mL; 40 mM Tris (pH 
8.0), 10 mM MgCl2, 10 mM dithiothreitol, 2 mM spermidine, 0.01% (v/v) Triton X-100, 4% 
(w/v) poly(ethylene) glycol 8000, 2 mM each NTP, PCR-generated template, T7 RNA 
polymerase; 37 °C; 4h].  Unsubstituted and nucleotide analogue-containing RNAs were 
synthesized using 0.1 and 0.2 mg/mL T7 RNA polymerase, respectively. RNAs were 
separated on a denaturing polyacrylamide gel (1× TBE, 8% polyacrylamide, 7 M urea, 29:1 
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acrylamide:bisacrylamide, 0.4 mm × 28.5 cm × 23 cm; 35 W, 1.5 h). Bands containing RNA 
were excised from the gel, and the RNA was recovered by overnight passive elution at 4 °C, 
followed by precipitation with ethanol. RNAs were resuspended in TE and stored at -20 °C. 
 
2.4.4 SHAPE of the GUAA stem loop 
RNAs (5 pmol) in 5 µL 1/2× TE were heated at 95 °C for 2 min, snap-cooled on ice, 
combined with 3 µL 3.3× folding buffer [333 mM Hepes (pH 8.0), 333 mM potassium 
chloride (pH 8.0), and 33 mM MgCl2], and incubated at 37 °C for 20 min.  SHAPE 
experiments were initiated by adding 9 µL of the refolded RNA to 1 µL 100 mM 1M7 (in 
DMSO) or neat DMSO. Reactions were incubated at 37 °C for 2 min. SHAPE adducts were 
detected by primer extension and quantified using ShapeFinder.(37)  Data sets were 
normalized by dividing the value for each nucleotide by the average of the three most 
reactive nucleotides (10% of the total). SHAPE data sets for the native and analogue-
containing RNAs were then re-scaled to the identical, single-stranded sequences in the 
flanking structure cassettes; SHAPE reactivities of these nucleotides were not affected by 
nucleotide analogue incorporation. 
 
2.4.5 SHAPE reactivity as a function of added base 
The [32P]-labeled adenosine-dideoxy cytosine (pAp-ddC; 1 µL, 100,000 cpm/µL) was 
incubated for 5 minutes at 37 °C in 8 µL 1.25× reaction buffer [62.5 mM HEPES (pH 8.0), 
125 mM sodium chloride, 12.5 mM MgCl2] containing either imidazole or pyrrole at 0, 
0.0375, 0.125, 0.375, 0.750, or 1.25 M (at pH 8.0).  Adduct formation was initiated by 
adding 9 µL of pAp-ddC-containing solution to 1 µL 100 mM 1M7 (in DMSO) or neat 
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DMSO. Reactions were incubated for 2 minutes at 37 °C. Reactions were diluted with 10 µL 
H2O and 20 µL formamide; 2 µL of the resulting solution was subjected to electrophoresis 
(1× TBE, 30% polyacrylamide; 29:1 acrylamide:bisacrylamide; 0.4 mm × 28.5 cm × 23 cm, 
35 W, 1 hr); bands were quantified by phosphorimaging. 
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Figure 2.1:  Scheme for SHAPE chemistry emphasizing that reactivity is governed 
primarily by the ability of a nucleotide to adopt a conformation that enhances the reactivity 
of the 2!-hydroxyl group towards SHAPE electrophiles. 
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Figure 2.2:  SHAPE chemistry performed on the 16S rRNA in 70S ribosome crystals 
identifies hyper-reactive nucleotides. (A) SHAPE reactivity histogram. Nucleotides that 
fall on the conventional SHAPE reactivity scale (normalized nucleotide reactivity <2) are 
black, nucleotides “hyper-reactive” towards SHAPE reagents are purple. (B) Section of data 
from part (A) showing two hyper-reactive nucleotides. One (nucleotide 412) has poor 
experimental electron density and is likely dynamic in the crystal, whereas the other 
(nucleotide 422) has well-defined density. Electron density is drawn at 1σ.
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Figure 2.3: Correlation between SHAPE reactivity and solvent accessibility at the O2!  
position for single-stranded nucleotides in the 16S rRNA. Probe sizes of 1.4 Å and 6.0 Å 
correspond to the approximate molecular dimensions of water and 1M7, respectively. 
Pearson’s linear r-values are shown.  
2'
-O
H
 s
ol
ve
nt
 a
cc
es
si
bi
lit
y 
(Å
2 )
SHAPE reactivity
1.4 Å
r = 0.20
A
6.0 Å
r = 0.15
0
5
10
15
20
25
30
35 B
0.1 1 10 0.1 1 1000
 37 
 
 
 
 
 
 
 
Figure 2.4: Venn diagram of hyper-reactive nucleotide conformations. Nucleotides in the 
C3'- or C2'-endo ribose conformations are illustrated in yellow and cyan, respectively. 
Nucleotides are grouped according to the distance between the 2!-hydroxyl and a vector 
bisecting the non-bridging oxygen bonds in the 3!-phosphodiester group (see Figure 2.5A) 
and proximity of the 2'-hydroxyl to a general base catalytic group. The conformation of 
hyper-reactive nucleotide A243 does not fall into any of these categories. 
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Figure 2.5. Nucleotides in which the 2'-OH group is close to a through-space group 
capable of hydrogen bond formation and general base catalysis. Nucleotides in the C3'- 
or C2'-endo ribose conformations are illustrated in yellow and cyan, respectively.  Through-
space neighbors are shown in gray with the hydrogen-bonding functional group illustrated 
with a red sphere. 
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Figure 2.6. Geometric characteristics of nucleotides hyper-reactive by SHAPE, 
compared to single-stranded nucleotides with low B-factors in 16S rRNA.  Rectangles 
span the central 50% of the data, the interquartile range, and the median is shown in a heavy 
line.  Whiskers above and below each box give the largest or smallest non-outlier values; 
nucleotides with values >1.5 times the interquartile range are shown with circles. Distances 
for each hyper-reactive pyrimidine and purine nucleotide are shown by colored boxes.  (A) 
Distance between the 2'-OH and the terminus of a vector bisecting the bonds to the non-
bridging oxygens in the 3'-phosphodiester. (B) Distance between the 2'-OH and pyrimidine 
O2. (C) Distance between the 2'-OH and purine N3. 
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Figure 2.7.  Effects of functional group substitutions on SHAPE reactivity. (A) Structure 
of the stem-loop RNA showing sites of nucleotide analogue incorporation during 
transcription. The bulged-A RNA contained flanking U sequences, and vice versa.  (B-D) For 
each substituted transcript, modifications are illustrated on the left and SHAPE reactivities 
for the modified (colored lines) compared to the unmodified transcript (black lines) are 
shown on the right. (B) 3'-Phosphorothioate (PS), (C) 2-thio-uridine (s2U), and (D) 3-deaza-
adenosine (3DA) functional group substitutions.  
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Figure 2.8. Effect of a solution-phase catalyst on SHAPE adduct formation. (A) 
Mechanism for general base catalysis of the reaction of a 2!-hydroxyl towards SHAPE 
reagents mediated by imidazole. (B) Imidazole- versus pyrrole-mediated enhancement of 2!-
O-adduct formation. 
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Figure 2.9. Mechanisms of RNA SHAPE chemistry. (A) Stabilization of the intermediate 
reactive 2'-oxyanion. In the five superimposed hyper-reactive nucleotides, the non-bridging 
oxygen groups of the backbone (and the permanent charge) are directed away from the 2'-OH 
group.  (B) General base catalysis.  Examples of catalysis by the pyrimidine O2, purine N3, 
pro-S oxygen, and through-space groups are shown.  For each panel, the number of 
occurrences observed in SHAPE analysis of 16S rRNA in crystallo is given in parentheses. 
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Figure 2.10. SHAPE reactivity histogram resulting from the average of three 
independent experiments.  Grey error bars represents the standard deviation for each 
nucleotide.  
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Table 2.1: Conformations of nucleotides with high SHAPE reactivities (0.7 – 
2.0), B-factor less than 60, and well-defined position in the ribosome crystal. 
 
Position Facilitating interaction(s) Conforms    Non-adjacent 
  to model interaction 
 
 235 5.1 Å PO-to-2'-OH distance a 
  3.4 Å distance to O4(236) 
 244 5.1 Å PO-to-2'-OH distance a 
 251 3.3 Å distance to OP2(268) ✔ ✔ 
    352 2.8 Å distance to O1P ✔ 
 561 2.5 Å distance to O1P ✔ 
 758 3.0 Å distance to N6(583) ✔ ✔ 
 789 2.6 Å distance to N7(791) ✔ ✔ 
    812 2.8 Å distance to N1(765) ✔ ✔ 
 867 2.6 Å distance to N1(873) ✔ ✔ 
 871 5.3 Å PO-to-2'-OH distance  
 911 3.1 Å distance to O4(912)  ✔ ✔ 
  5.3 Å PO-to-2'-OH distance  
 912 5.2 Å PO-to-2'-OH Å distance ✔ 
 1201 2.0 Å distance to O1P(1200)  ✔ ✔ 
  2.5 Å distance to OP  
 1396 2.7 Å distance to O1P(15)  ✔ ✔ 
 1403 3.2 Å distance to N1(1499)  ✔ ✔ 
 1404 2.8 Å distance to O2'(1519)  ✔ ✔ 
 1467 5.1 Å PO-to-2'-OH distance  a 
 1468 2.6 Å distance to O2'(318)  ✔ ✔ 
 
a Does not fully conform.  PO vector is oriented away from the 2'-OH but is not as 
long as for the hyper-reactive nucleotides. Numbers in parentheses indicate 
interactions on non-adjacent nucleotides. 
 
 
 
 
 
 
CHAPTER 3 
  
Role of Transcription on the Steady-State Structure of 16S rRNA in the 
Cell 
 
 
3.1  Introduction 
RNA molecules play essential roles in diverse cellular functions.  Most of these 
functions depend on the ability of the RNA to fold into a stable structure (1).  In the cell, 
endogenous RNAs likely adopt many intermediate structures before the final functional 
structure is formed (2-4).  These structural changes occur in an environment very different 
from that of most in vitro explorations of RNA structure-function relationships. RNAs must 
be transcribed, associate with proteins, and function in a complex cellular environment.  Few 
methodologies exist for assessing RNA structure and function in vivo at nucleotide 
resolution. 
 
3.1.1  SHAPE chemistry is ideal for probing RNA structure in vivo 
Selective 2!-hydroxyl acylation analyzed by primer extension (SHAPE) takes 
advantage of the discovery that the reactivity of the 2!-hydroxyl position is highly sensitive to 
local nucleotide flexibility (5, 6).  Flexible nucleotides sample many conformations, a few of 
which preferentially react with hydroxyl-selective electrophilic reagents to form 2!-O-adducts 
(7) (Figure 3.1A). The adducts are then detected by primer extension.  Since SHAPE 
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reagents react with all four nucleotides (8), quantitative information about local nucleotide 
flexibility can be obtained simultaneously at almost all positions in an RNA in a single 
experiment. 
SHAPE chemistry possesses several features that make it ideal for probing RNA 
structure in vivo. The reagents used for modification, like 1-methly-7-nitro-isatoic anhydride 
(1M7), are small and hydrophobic, so these molecules should readily cross the cellular 
membrane to modify RNA structures inside the cell.  The reagents are also self-quenching 
(Figure 3.1A), which simplifies the experiment and is less disruptive to the cellular 
environment.  Conditions used during SHAPE modification result in ~1 modification every 
300 nucleotides, so these adducts should be less disruptive to the RNA structure compared 
with other chemical probes such as DMS.  Primer extension, is by nature, RNA-specific, so 
careful design of primers allows detection of only the RNA of interest.  
 
3.1.2  Ribosomal RNA must undergo many structural transitions to function 
The 1542-nucleotide 16S ribosomal RNA (rRNA) of the Escherichia coli represents 
an ideal target to determine if 1M7 can cross the cell membrane and modify the RNA in a 
structure specific manner.  First, rRNA makes up 80% of total RNA in the cell (9). Second, 
16S rRNA has been well-characterized in vitro using biochemical and crystallographic 
techniques (10-12).  Third, although the 70S ribosome, and specifically the 16S rRNA, has 
been studied intensively in vitro, little is known about 16S rRNA structure in vivo. 
In the cell, the 16S rRNA undergoes a series of complex events during its “lifetime”: 
The RNA is must be transcribed, processed to the mature full-length form, and certain 
nucleotides modified; concurrently, it folds back on itself, associating with ribosomal 
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proteins to form the 30S subunit. Much of 30S assembly is unknown in terms of the RNA 
structure.  Upon association with initiation factors and the 50S subunit, the 16S rRNA 
becomes part of the 70S ribosome. This large complex associates with elongation factors, 
tRNA, and mRNA during elongation to translate messenger RNA (mRNA) into a 
polypeptide sequence.  Upon finishing translating the mRNA, it then associates with 
recycling factors and is ready to begin another round of translation. Finally, the ribosome is 
disassembled and the RNA is degraded (13, 14).   
When SHAPE is used to probe the 16S rRNA in live bacterial cells, the resulting 
structural profile will be a composite of the structures adopted at each of these stages.  
During mid-log phase most (85-95%) of the 16S rRNA sediments as polysomes and 
monosomes, implying that most of the 16S rRNA will be part of actively translating 
ribosomes under these experimental conditions (15). 
 In this chapter, I report the SHAPE analysis of the steady-state structure of the 16S 
rRNA in live cells.  I show that the structure is flexible and inconsistent with the 
crystallographically determined structure of 16S rRNA within the 70S ribosome (11).  When 
transcription was inhibited, SHAPE analysis indicated that the 16S rRNA became 
significantly more structured and likely represents the 16S rRNA within 30S subunits and 
70S ribosomes. 
 
3.2  Results 
3.2.1  Cell viability under SHAPE conditions 
In a standard SHAPE experiment, the SHAPE reagent is disolved in an anhydrous 
organic solvent, such as DMSO, to prevent premature hydrolysis. In order to confirm that 
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DMSO does not affect bacterial viability, varying concentrations of DMSO were added to a 
culture of E. coli cells in Luria Broth (LB), and the growth was monitored by measuring the 
absorbance at 600 nm (Figure 3.1B).  In the absence of DMSO, cells required ~200 minutes 
to reach mid-log phase (OD600 = 0.6), and at 700 minutes had a final cell density of ~2.8 
optical density units at 600 nm (ODU) (Figure 3.1B).  Cells grown in the presence of 10 % 
DMSO grew significantly more slowly (Figure 3.1B), requiring nearly 600 minutes to reach 
OD600= 0.6.  Additionally, the final cell density was much lower (OD600 = 1.4) even after 25 
hours (data not shown), suggesting that significant cell death occurs at high concentrations of 
DMSO.  However, cells grown in lower percentages of DMSO exhibited the same growth 
rate as cells grown in the absence of DMSO (Figure 3.1B). In 2 and 4% DMSO, cultures 
reached an OD600 of 0.6 in ~200 minutes, and final cell densities at 650 minutes were 
approximately the same as for cells grown without DMSO. Thus, in vivo SHAPE can be 
performed using DMSO concentrations of 2-4% (v/v) without impacting bacterial cell 
viability. 
 
3.2.2 Determination of the in vivo SHAPE reaction time scale 
  The hydrolysis rate of 1M7 in LB was determined at pH 6.5 (corresponding to the 
pH of the culture media at the beginning of cell growth) and pH 7.0 (corresponding to the pH 
of LB at mid-log growth).  Pseudo-first order rate constants were obtained by monitoring the 
absorbance of the hydrolysis product (2-methylamino-4-nitrobenzoate) at 430 nm (Figure 
3.1C).  Since the hydrolysis half-life of 1M7 at pH 7 was 24 sec, the reaction at mid-log 
phase will be complete in approximately 2 minutes (5 hydrolysis half-lives).  The 
intracellular pH of E. coli is maintained at ~7.5-7.8 (16, 17), so it is likely that 1M7 
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hydrolysis inside the cell occurs at faster rate than the hydrolysis measured in LB.  Thus, 
performing in vivo SHAPE at mid-log phase of cell growth will result in modification of 
cellular RNA structures over approximately a 2-minute interval. 
 
3.2.3 In vivo modification of RNA by SHAPE 
 To determine whether 1M7 crosses the cellular membrane and modifies RNA in live 
E. coli, cell cultures grown to mid-log phase (OD600=0.6) were added directly to 1M7 in 
DMSO (3% vol/vol) (Figure 3.2A).  After the in vivo modification, the cells were pelleted 
and lysed, the cellular debris and proteins removed, and the total cellular RNA purified.  The 
sites of in vivo 2!-O-adduct formation in the 16S rRNA were resolved by primer extension 
and capillary gel electrophoresis. For the large 1542-nt 16S rRNA, five sets of DNA primers 
were used designed to anneal to the rRNA ~300 nucleotides apart (see Methods).  Over 1,450 
nucleotides in the 16S rRNA were analyzed.  Representative data for sixty nucleotides are 
shown in Figure 3.2B.  A dideoxy sequencing reaction was performed using cellular RNA 
(Figure 3.2B, black trace). There were few erroneous peaks indicating that the primers used 
are specific for the 16S rRNA.   
When cells were treated under standard in vivo SHAPE conditions, but the SHAPE 
reagent omitted, very small peaks were observed (Figure 3.2B, green trace). These peaks are 
due to imperfect enzyme processivity and are consistent with little or no RNA degradation 
occurring under in vivo SHAPE conditions. In contrast, when cells were treated with the 
SHAPE reagent, 1M7, large peaks were observed (Figure 3.2B, blue trace) corresponding to 
nucleotides modified by 1M7 in vivo.  Thus, 1M7 is able to cross the cellular membrane and 
modify RNA in vivo. 
 50 
 
3.2.4 Determination of the steady-state in vivo 16S structure by SHAPE  
Absolute SHAPE reactivities were obtained for approximately 94% of the nucleotides 
in the 16S rRNA.  This in vivo structural profile represents the steady-state structure of the 
16S rRNA in live cells at the mid-log phase of growth. To evaluate whether SHAPE data 
obtained in vivo provides accurate and quantitative information regarding RNA structure, in 
vivo SHAPE reactivities were superimposed onto the accepted secondary structure model of 
the E. coli 16S rRNA derived from comparative analysis (18, 19). For most nucleotides in the 
16S rRNA, the in vivo SHAPE reactivities are in good agreement with the accepted 
secondary structure (Figure 3.3, grey highlights); single-stranded nucleotides in the model 
show high or medium reactivity whereas nucleotides expected to be base-paired are not 
reactive with SHAPE reagent.   
A few nucleotides expected to be single-stranded based on the secondary structure 
model exhibited very low SHAPE reactivity.  Since SHAPE provides a robust measure of 
molecular motion (20), it is likely these nucleotides are involved in tertiary contacts or 
protein binding.  These unreactive nucleotides were examined in context of the 16S rRNA 
structure obtained from the 70S crystal structure (11).  Almost all of these unreactive 
nucleotides are indeed involved in RNA tertiary interactions or are located within or near 
protein binding sites (Figure 3.3, black stars).  For example, in the crystal structure, the 
unreactive nucleotides 260-265 interact with the bulged nucleotides 132-135, which were 
also unreactive to SHAPE reagent, by a direct RNA-RNA interaction. Additionally, 
unreactive looped nucleotides 321-323, 326-330, and 260-265 are all located near the 
protein-binding site of S20, which is one of the first proteins to bind during 30S assembly 
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(14). These tertiary interactions are consistent with the low degree of flexibility measured by 
SHAPE in vivo. Overall, there is ~90% agreement between in vivo SHAPE reactivities and 
the 16S rRNA accepted secondary structure model based on comparative analysis.  Thus, 
SHAPE can be used to accurately report on RNA structure in vivo.  
 
3.2.5  Identification of possible secondary structure rearrangements in the in vivo 
steady-state 16S structure 
 
 Approximately 10% of 16S nucleotides predicted to be base-paired in the accepted 
structure exhibited high or medium SHAPE reactivities (Figure 3.3., magenta and cyan 
boxes).  Of the 13 helices in which these nucleotides are located, eight have nucleotides on 
both sides of the helix that were reactive (H2, H3, H16/H17, H26b, H28, H36, and H41).  For 
example, in helix 26b, nucleotides 829-831 and 854-855 (Figure 3.3, magenta box) are 
expected to be base -paired, and thus unreactive to 1M7.  However, these nucleotides were 
modified by 1M7, making it unlikely that this helix is fully folded in the in vivo steady-state 
16S structure.  In five helical regions (H12, H31, H33b, H34, and H38) SHAPE-reactive 
nucleotides are adjacent to unreactive nucleotides that are single-stranded in the accepted 
secondary structure.  In these regions, the base pairs formed in vivo may differ from those 
predicted by the accepted secondary structure model. 
To identify possible alternative structures in these discrepant regions, in vivo SHAPE 
data was used to direct RNA folding as previously described (21). In four of the five helical 
regions (Figure 3.3, cyan boxes), base pairings predicted using SHAPE pseudo free energy 
terms (Figure 3.3, purple lines) were more consistent with the experimental SHAPE 
reactivities than the base pairs in the accepted secondary structure.  For example, in helix 34 
(Figure 3.3, cyan box), the in vivo SHAPE reactivities are inconsistent with the accepted 
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secondary structure; nucleotides 1055 and 1200-1202 are bulged, but are unreactive in vivo, 
whereas nucleotides 1053, 1204, and 1205 are base-paired, but are reactive in vivo.  In the 
SHAPE-directed structure, nucleotides 1200-1202 are predicted to base pair with nucleotides 
1057-1055 (Figure 3.3, purple lines), and nucleotides 1053, 1054, and 1203-1205 are bulged. 
This alternative base-pairing pattern is more consistent with the measured in vivo nucleotide 
dynamics than is the accepted structural model.   
 
3.2.4 The steady-state 16S structure in vivo differs when transcription is halted 
One hypothesis for the discrepancies between the in vivo experimental SHAPE 
reactivities and the accepted secondary structure is that the in vivo steady-state 16S rRNA 
structure reflects the structure of 16S rRNA before incorporation into 70S ribosomes.  
Although only 10% of the nucleotides probed in vivo have SHAPE reactivities not consistent 
with the accepted secondary structure, many bulged and looped nucleotides that are 
constrained by tertiary interactions in the 70S ribosome are reactive to SHAPE in vivo.  For 
example, looped nucleotides 1358:1364 are highly constrained by a direct RNA-RNA 
interaction with nucleotides 1315:1319 in the crystal structure, but are highly reactive in vivo.   
At mid-log phase, cells are actively dividing, necessitating the production of 
ribosomal RNA.  This could result in a large amount of 16S rRNA in the cell, much of which 
has not been incorporated into ribosomes.  If this hypothesis is correct, then halting 
transcription to stop the production of new 16S rRNA should result in assembly of most 16S 
rRNA into 70S ribosomes.  The steady-state structure in the absence of transcription should 
be less flexible, and thus less reactive towards SHAPE reagents, than the structure observed 
in actively growing cells.  To test this hypothesis, the antibiotic rifampicin, which inhibits 
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transcription, was added to cells when the OD600 reached 0.5.  Rifampicin halts initiation of 
transcription within 70 seconds of addition, and it takes approximately 2.2 minutes for 
transcription of an rRNA operon (22) and approximately 2 minutes for the rRNA to be 
processed and fully folded (23).  To ensure that the majority of rRNA is properly folded prior 
to addition of SHAPE reagent, cells were incubated with rifampicin for 20 and 60 minutes 
before modification with 1M7. Since no appreciable differences in SHAPE reactivity were 
observed between 20 and 60 minutes (data not shown), the SHAPE reactivity profile of the 
16S rRNA after transcription had been halted for 20 minutes was analyzed.   
Rifampicin inhibits the bacterial RNA polymerase, but does not bind to the ribosome 
so any changes in SHAPE reactivity observed in the 16S rRNA should be due to the effects 
of arrested transcription rather than direct effects on the RNA structure. The SHAPE 
reactivities in the absence of transcription are shown on the 16S rRNA secondary structure 
(Figure 3.4).  Strikingly, more than half (273/509) of the nucleotides that were reactive in 
vivo (nts with SHAPE reactivities > 0.4, excluding hyper-reactive nts [>3 SHAPE units]) 
exhibited a significant decrease (greater than 0.3 SHAPE units) in reactivity upon rifampicin 
addition (Figure 3.5, highlighted in blue).  These data are consistent with the 16S rRNA 
becoming more structured after transcription is arrested. 
Moreover, almost all of the nucleotides that were reactive in base-paired regions of 
the accepted secondary structure (Figure 3.3, magenta and cyan boxes) were un-reactive after 
transcription was inhibited (Figure 3.4, magenta and cyan boxes).  For example, the mean in 
vivo SHAPE reactivity of nucleotides comprising H33b decreased from 0.5 to 0.2 SHAPE 
units when transcription was halted, consistent with the formation of the base pairs in the 
accepted secondary structure.  Of all of the nucleotides that decreased by more than 0.3 
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SHAPE reactivity units in the absence of transcription, 88 (~32%) were nucleotides expected 
to be base-paired in the accepted model. The arrest of transcription resulted in an in vivo 
SHAPE profile that was at least 99% consistent with the secondary structure predicted based 
on covariance. 
Less than 1% of the 16S rRNA nucleotides increased by more than 0.3 SHAPE 
reactivity units upon rifampicin addition (Figure 3.4, circled in orange).  These nucleotides 
are almost all in single-stranded regions.  In previous studies our laboratory has shown that 
increased global RNA structure formation can result in single nucleotides to be constrained 
in a conformation that enhances the nucleophilicity of the 2!-hydroxyl (7), such that they 
become hyper-reactive towards SHAPE reagents. However, none of the nucleotides that 
increased in SHAPE reactivity upon halting transcription were hyper-reactive.  The increased 
in vivo SHAPE reactivity upon rifampicin addition may indicate changes in loop dynamics 
that cannot entirely be rationalized based on our current data. 
During rRNA processing, RNase III cleaves the primary 16S rRNA transcript to 
generate a precursor form of the 16S rRNA (17S rRNA) that contains an additional 115 
nucleotides on the 5! end and 33 nucleotides at the 3! end (24). The relative amount of the 
17S precursor relative to mature 16S rRNA can be quantified by primer extension analysis of 
the 5! terminus of the rRNA (25). To confirm that levels of 17S precursor rRNA decrease 
after rifampicin addition to cells, primer extension was performed to quantify 16S and 17S 
levels.  In log-phase cells without addition of antibiotic, we found that 16% of the total rRNA 
contained an unprocessed 5! end.  When rifampicin was added to halt transcription the 
percentage of RNA with an unprocessed 5! end decreased to 2.5%. 
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Ribosomal RNA likely folds and assembles into 30S subunits co-transcriptionally 
(14).  If the changes in SHAPE reactivity upon rifampicin addition are indicative of folding 
and assembly of essentially all of the 16S rRNA in the cell into 30S subunits and 70S 
ribosomes, then regions of the 16S rRNA that fold first (the 5! domain) should be least 
affected and regions that fold last (the 3! domain) should be most affected by inhibition of 
transcription.  The sum of the number of rifampicin-responsive nucleotides (RR-nts), those 
nucleotides that decreased in reactivity upon treatment of cells with rifampicin, was 
calculated over 50-nucleotide windows (Figure 3.5A). There is a clear trend towards an 
increase in RR-nts from the 5! domain to the 3! domain. Additionally, sharp increases in the 
number of RR-nts are observed at either side of the junctions between domains.  
The nucleotides that become less reactive to 1M7 upon treatment of cells with 
rifampicin are highlighted on the crystal structure partitioned into the RNA domains in 
Figure 3.5B.  When transcription was halted, 9.6% (54/562) of the nucleotides in the 5! 
domain and 13.8% (48/346) of the nucleotides in the central domain were less reactive to 
1M7 (Figure 3.5B).  In contrast, 29.6% (143/483) of the nucleotides in the 3! major domain 
and 35% (27/77) of the nucleotides in the 3! minor domain exhibited a significant decrease in 
SHAPE reactivity after transcription inhibition.  In sum, these data are consistent with the 
order of  co-transcriptionally folding during ribosomal assembly. 
In addition to showing a clear 5! to 3! trend, the moving window of rifampicin-
responsive nucleotides (Figure 3.5A) also revealed a relatively large number of RR-nts 
adjacent to the junctions between RNA domains.  To determine whether the nucleotides that 
become less reactive to 1M7 upon inhibition of transcription are involved in higher order 
structure interactions, we calculated solvent accessibility at the 2!-OH to assess which RR-nts 
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were likely involved in RNA-RNA domain interactions, RNA-protein interactions, and 
subunit association interactions.  Although SHAPE reactivities are not governed by solvent 
or molecular accessibility (7, 26), this calculation provides a way of robustly quantifying 
RNA interactions by proximity.  By calculating the solvent accessibilities of the 16S rRNA 
2’-hydroxyl groups in the crystal structure and comparing these to accessibilities in the 
complex of 16S rRNA with 30S proteins, the rifampicin-responsive nucleotides that are 
directly involved in RNA-protein interactions were revealed (Figure 3.6A, yellow spheres).  
Those RR-nts in proximity to RNA-RNA domain interactions (Figure 3.6A, green spheres) 
and to the 50S subunit (Figure 3.6A, purple spheres) were also determined.  
Most of the rifampicin-responsive nucleotides involved in direct RNA-RNA domain 
interactions are located in the central domain and make contact with the 3! minor domain.  
This is consistent with the fact that the 3! minor domain is the last domain to fold during 
ribosome assembly.  The second cluster of rifampicin-responsive nucleotides (Figure 3.6A, 
green spheres) are located around the central pseudoknot that connects the 5! and 3! major 
domains and are in proximity to the junctions of the central and 3! minor domains.  The 13 
helical regions predicted by SHAPE-based modeling that do not agree with the accepted 
secondary structure (Figure 3.3, cyan and magenta boxes) involve many of the rifampicin-
responsive nucleotides. 
Our analysis implies that the RNA secondary structure must change in order for the 
RNA domains to interact.  We hypothesized that the regions that are rifampicin-responsive 
are among the last to fold and associate with the 30S proteins.  If so, these nucleotides should 
reside adjacent to regions bound by late, or tertiary binding, proteins (S2, S3, S5, S10, S12, 
S14, and S21) (27, 28). In the crystal structure, 12 of the 13 helical regions predicted by 
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SHAPE-based modeling that do not agree with the accepted secondary structure (Figure 
3.7A) reside near the binding sites of late-binding proteins (Figure 3.7B). This implies that 
the binding of these proteins triggers several RNA structural changes necessary for the 16S 
rRNA to fold into its active structure. 
 
3.3  Discussion 
3.3.1  SHAPE accurately maps RNA structure in vivo 
I have developed a straightforward protocol for evaluation of RNA structure in 
bacterial cells using SHAPE chemistry.  I have shown that the SHAPE reagent 1M7 readily 
traverses the complex cell wall of the E. coli bacterium to modify RNA in a structure-
selective manner.  I used in vivo SHAPE to determine the 2-minute structural average of 16S 
rRNA in live cells.  There was over 90% agreement between in vivo SHAPE reactivities and 
the phylogenetic model for the secondary structure of 16S rRNA.  Thus, SHAPE chemistry 
provides a rapid and accurate way to probe RNA structure in vivo at single-nucleotide 
resolution.   
 
3.3.2 The steady-state structure of the 16S rRNA at mid-log phase is inconsistent with 
the structure of 16S rRNA in 70S ribosomes 
 
The 16S rRNA, when incorporated into 70S ribosomes, is highly structured and 
largely unreactive towards chemical probes (7, 29).  Most nucleotides that are single-stranded 
in the secondary structure are involved in tertiary structures that make them unavailable to 
chemical probes.  Previous studies have estimated that 85-95% of ribosomal RNA sediments 
as polysomes and monosomes at mid-log phase and have estimated that only ~5% of the total 
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rRNA in the cell is not mature (15).  If, at the time of modification, most of the rRNA was 
part of 70S ribosomes, we would expect the steady-state structure to be largely unreactive.  
However, the SHAPE reactivity profile of the average 16S in vivo implies a large degree of 
flexibility.  This is inconsistent with the very structured nature of the 16S rRNA when 
incorporated into 70S ribosomes.  
One reasonable interpretation of these data is that there is a much larger amount of 
free 16S rRNA in the cell than previously anticipated.  Several of our results are consistent 
with this hypothesis. First, primer extension analysis of the 5! end of the 16S rRNA indicated 
that 16% of the total 16S rRNA is part of a precursor transcript that has not been fully 
enzymatically processed to the mature state. Second, I identified 13 helical regions in the 16S 
rRNA average structure that contained nucleotides reactive to SHAPE, inconsistent with the 
secondary structure predicted based on phylogenetic analysis.  The majority of these regions 
(12/13) reside near the binding sites for late-binding proteins (Figure 3.7B).  We interpret this 
to mean that late-binding proteins are not bound to most of the 16S rRNA present in bacterial 
cells under our analysis conditions.   
Furthermore,  many more nucleotides in the RNA were reactive towards SHAPE than 
expected from the highly ordered tertiary structure of the 16S rRNA when incorporated into 
70S ribosomes.  For example, nucleotides that form the well-characterized central 
pseudoknot were reactive towards 1M7 (Figure 3.3, H2).  Additionally, nucleotides that 
make RNA-RNA interactions near the pseudoknot were also reactive.  Therefore, these 
structures have not formed, on average, in the 16S rRNA present in the bacterial cells during 
mid-log phase growth.     
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When transcription was inhibited by addition of rifampicin to cells in mid-log phase 
and time was allowed for the 16S rRNA to fold and assemble into 30S subunits and 70S 
ribosomes prior to the SHAPE experiment, more than half of the nucleotides that were 
flexible in the presence of active transcription became more constrained. Most of the 
nucleotides that decreased in SHAPE reactivity are part of the 3! domain, which is the last to 
fold.    These data are consistent with the hypothesis that the steady-state 16S rRNA structure 
shifted towards a more structured species in the absence of transcription, likely finishing 
assembling into 30S subunits.  
 
3.3.3 Evidence that late-binding proteins induce a large RNA structural rearrangement 
For the 30S subunit to form and function during translation the 16S rRNA must not 
only fold into its correct secondary structure but also form tertiary interactions, associate with 
ribosomal proteins, and associate with the 50S subunit.  Many of the nucleotides that become 
less susceptible to 1M7 when transcription is inhibited are located in regions that are 
involved in these specific interactions (Figure 3.6A).  Interestingly, it was observed that 
many rifampicin-responsive nucleotides were clustered directly adjacent to domain junctions 
(Figure 3.5A), suggesting that the domains fold somewhat independently and then associate 
to form the final 30S structure.  Many of the rifampicin-responsive nucleotides involved in 
interactions between domains are contained in, or are adjacent to, the helical elements that do 
not form in the steady-state structure.  Many of these helical elements are in close proximity 
to regions bound by late binding proteins (Figure 3.7B). This implies that the binding of 
certain proteins triggers a large RNA structural change necessary for the 16S rRNA to finish 
folding into its active structure. 
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3.3.4  Biological implications of in vivo 16S rRNA dynamics 
If the steady-state 16S rRNA structure is heavily influenced by the presence of the 
precursor transcript and by incompletely assembled 16S rRNA, it is likely that nucleotides 
reactive towards 1M7 under normal cell conditions undergo important dynamics in the cell.  
For example, regions identified as being structurally inconsistent with the accepted secondary 
structure or that strongly decreased in reactivity when transcription was halted could be 
important for 30S assembly.  Interestingly, eight (H2, H12, H28, H31, H36, H34, H4, and 
H44) of the 13 regions with reactive nucleotides that are in helices in the accepted structure 
contain nucleotides that when modified in vitro interfered with ribosome assembly (28).  The 
other six helical regions with reactive nucleotides (H33, H38, H16/17, H6, H26b, and H3) 
might also be critical for proper ribosome assembly in vivo.   
I identified at least four regions where SHAPE data are in agreement with the 
accepted structure when transcription is inhibited and suggest a different structure in the 
presence of transcription (Figure 3.4, cyan boxes).  This implies that the 16S rRNA folds into 
metastable intermediate structures prior to rearrangement to form the secondary structure 
observed in ribosomes.  Interestingly, there is strong covariation support for the SHAPE-
supported alternative base-pairing patterns in H12 and H34 (Zhang et al., unpublished 
results). Moreover, mutating G1053 (H34) to A, C, or U, results in nearly undetectable levels 
of translation and a nearly 3.5-fold increase of free 30S subunits relative to 70S ribosomes 
(28).  Though this does not provide direct support for the alternative base pairs suggested by 
SHAPE modeling, it does highlight the importance of this area in the 16S rRNA. 
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In vitro, 30S assembly takes place in two stages (14).  The early stage is characterized 
by rapid protein binding and results in a variety of assembly intermediates (30). The later 
stage is thought to be cooperative and to take place by an induced fit model.  It has been 
hypothesized that assembly in vivo is more cooperative than the process observed in vitro and 
that specific accessory factors may limit the number of intermediates that can be populated 
(27, 30).  The data presented here may help to determine the in vivo viability of these in vitro 
intermediates.  
 
3.3.4  Implications for novel antibiotic drug targets 
 Many clinically useful antibiotics interfere with protein synthesis by inhibiting 
ribosome function (31).  However, these antibiotics act on a fairly small number of sites 
within the ribosome.  Since the ribosome is large, complex, and highly conserved, it can be 
difficult to identify sites of functional importance that will target bacterial but not human 
ribosomes (32). Here, I have identified areas in the 16S rRNA that undergo structural 
dynamics that are not part of the traditionally highly conserved active sites of the ribosome.  
These regions may be important to bacterial ribosome assembly but not to eukaryotic 
ribosome assembly; if so, some of these regions could provide novel drug targets.  One 
interesting possibility is helix 33.  In human ribosomes, this helix is bound to protein S31e 
(33).  In bacteria, helix 33 is made up of two helices, helix 33a and helix 33b.  In eukaryotes, 
helix 33a does not exist (34).  Based on the structure derived from experimental SHAPE 
data, we propose that in bacteria, helix 33 undergoes an RNA structural change during 
assembly (Figure 3.3).  If the proposed helical switch is necessary for bacterial ribosomal 
biogenesis, this could represent a good future drug target as it seems unlikely helix 33 is 
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necessary for human ribosomes.  Future work is necessary to determine the feasibility of this 
idea. 
 
3.3.5 Summary 
In sum, I have shown that the steady-state 16S rRNA structure in live E. coli during 
the mid-log phase of growth is heavily influenced by 16S rRNA that has not yet been 
incorporated into ribosomes. Additionally, I have shown that by inhibition of transcription, 
SHAPE can be used to identify key structural changes in the 16S rRNA that must occur for 
70S assembly.  This suggests that transcription of rRNA and the translation process are more 
closely linked than previously envisioned.  Finally, I have identified regions in 16S rRNA 
that are likely necessary for the proper in vivo assembly of the 16S rRNA into 70S 
ribosomes. SHAPE chemistry provided a rapid and accurate way to probe RNA structure in 
vivo at single-nucleotide resolution.  In this study, I used SHAPE to examine the endogenous 
16S rRNA in bacterial cells, in the future, in vivo SHAPE can be used to study the steady-
state RNA dynamics of other RNAs in other types of cells. 
 
3.4  Experimental 
3.4.1  Cell viability in DMSO 
 DH5α cells (500 mL) were grown in LB to an OD600 of 0.3 starting from 5 mL of an 
overnight culture.  Cell aliquots (10 mL) were then added to 90 mL of LB containing 0, 2, 4, 
6, 8, or 10% (v/v) DMSO.  Samples were withdrawn at intervals and the OD600 was 
measured. 
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3.4.2 Hydrolysis of 1M7 in LB media 
 Hydrolysis of 1M7 was followed by addition of 2.0 mM 1M7 in 100 µL DMSO to 
900 µL LB (pH 6.5 or 7.0) pre-equilibrated at 37 °C in a cuvette.  Pseudo-first-order rate 
constants were obtained by monitoring the absorbance of the hydrolysis product (2-
methylamino-4-nitrobenzoate) at 430 nm. 
 
3.4.3 SHAPE analysis of the steady-state 16S rRNA structure in vivo 
 DH5α cells (500 mL) were grown in LB to an OD600 of ~0.6 starting from 5 mL of an 
overnight culture.  In vivo RNA modification was initiated by adding an aliquot of the cell 
culture (14 mL) to 433 µL of 166.67 mM 1M7 in DMSO (5 mM 1M7 final). The control cell 
sample was treated with neat DMSO (3% vol/vol). Samples were allowed to react with 
shaking for ~2-5 min at 37 °C.  An untreated aliquot of cell culture was also harvested for 
dideoxy sequencing.  Cells were collected by centrifugation (4,0000 g for 20 min, 4°C).  Cell 
pellets were resuspended in 200 µL of TE buffer containing 30 mg/mL lysozyme and 
incubated on ice for 5 min.  Total cellular RNA was purified using the Qiagen RNeasy Mini 
kit.  RNA concentration was determined by absorbance at 260 nM. 16S rRNA concentration 
was estimated by assuming that 16S rRNA represents 40% of total cellular RNA.  For all 
samples, the purified RNA contained all cellular RNA.  
For experiments in which transcription was inhibited, cell growth was initiated as 
above. At an OD600 of ~0.5, 50 mL of cells were added to either 5.55 mL of rifampicin in 
H2O (final concentration of 18.75 µg/mL, 10%) or 5.55 mL H2O. Cells were incubated with 
vigorous shaking for 20 min and then in cell SHAPE was performed as described above. 
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3.4.4 Primer extension 
 Five primers of 19-22 nucleotides were used for analysis of 16S rRNA. The 3! 
positions of the primers were complementary to 16S rRNA positions 323, 559, 947, 1112, 
and 1492 (7). The DNA primers were 5!-end labeled with either VIC or NED fluorophores 
(Applied Biosystems).  The VIC-labeled primer was used for the (+) or (–) 1M7 channel.  
The NED was used for the sequencing channel.  The modified RNA (1.5 pmol) and primer (2 
pmol) were mixed and diluted to 13 µL with H2O.  The primers were annealed for 6 min at 
65 °C and then cooled on ice.  Reverse transcription buffer [6 µL; 167 mM Tris-HCl (pH 
8.3), 250 mM KCl, 10 mM MgCl2, 1.67 mM each dNTP] and Superscript III (1 µL, 200 
units) were added, and samples were incubated at 45 °C for 2 min, 52 °C for 60 min, then 65 
°C for 5 min.  The reaction was quenched with 4 µL 50 mM EDTA.  The cDNAs were 
recovered by ethanol precipitation, washed twice with 70% ethanol, dried at 65 °C for 5 min, 
and resuspended in 10 µL deionized formamide.   
Dideoxy sequencing ladders were produced using unlabeled, unmodified total cellular 
RNA in the protocol outlined above except the reaction was diluted to 12 µL with H2O and 1 
µL 2!,3!-dideoxycytidine (5 mM) triphosphate was added before addition of Superscript III. 
cDNA fragments were separated by capillary electrophoresis using the Applied Biosystems 
3500 DNA sequencing instrument. 
 
3.4.5  Data analysis 
 Raw capillary electrophoresis traces were analyzed using QuSHAPE (Karabiber et 
al., submitted).  SHAPE reactivities for each experiment were obtained by subtracting the no-
reagent background integrated areas from the (+) reaction integrated areas.  All datasets were 
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normalized using QuSHAPE; the algorithm uses model-free statistics to normalize the data to 
a scale of 0 to ~2.  Nucleotides with normalized SHAPE reactivities 0-0.4, 0.4-0.85, and 
>0.85 correspond to unreactive, moderately reactive, and highly reactive positions, 
respectively.  Each experiment was performed at least twice, and data were reproducible.  
 
3.4.6  RNA structure prediction 
 Alternative secondary structures were generated using the structure prediction 
program RNAstructure (35) in conjunction with a pseudo-free energy change constraint 
calculated from the normalized SHAPE reactivity information (21, 36).  Segments of the 
RNA were folded using the following definitions: helix 12 (nts 290:310), helix 33 (nts 994-
1044), helices 34-39 (nts 1059-1198). 
 
3.4.7 Surface accessibility calculation  
Solvent accessibility surface area (SASA) at the 2!-hydroxyl was calculated using 
NACCESS 2.1.1 (http://www.bioinf.machester.ac.uk/naccess/) with a probe size of 2.8 Å 
using the atomic coordinates from 3I1M.pdb (30S) and 3I1N.pdb (50S) (11).  Nucleotides 
were considered surface nucleotides if the SASA was greater than 5 Å2.  
Nucleotides at the subunit interface of the 30S were defined by nucleotides that 
became inaccessible when the 50S was added in the calculation.  Nucleotides in the 16S 
rRNA in direct contact with proteins were defined by nucleotides that became inaccessible 
when 30S proteins were added in the calculation.  Nucleotides in the 16S rRNA that were 
involved in RNA-RNA domain interactions were defined by nts that became inaccessible 
when the other domains were included in the calculation.  For domain calculations, the 
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following definitions were used: 5! (nts 1-566), central (nts 567-912), 3!-major (nts 913-
1396), 3!-minor (nts 1397-1542). 
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Figure 3.1 SHAPE chemistry conditions are compatible with analysis of RNA structure 
in live cells. (A) Schematic of the mechanism of SHAPE chemistry. (B) Effect of DMSO 
concentration on E. coli growth rate. (C) Pseudo-first order hydrolysis of 1M7 in Luria Broth 
(37 °C) at pH 6.5 (circles) and pH 7.0 (squares); pH of the culture media is initially 6.5 and 
at 7.0 at the mid-log phase of cell growth.  For clarity, every fifth data point is shown. 
(RNA)flexible(RNA)constrained
2'OH 2'OH
(RNA)
2'O
2'-O-adduct
N
OO O
N
O
H
CO2
NO2
1M7
NO2
0 200 400 600
0
1
2
3
 
O
D
60
0 
(a
rb
. u
ni
ts
)
Time (min)
DMSO (%)
10
8
6 
4
2
0
Cell viability in DMSO
A
bs
or
ba
nc
e 
at
 4
30
 n
m
0
0.1
0.2
0 100 200 300 400 500
Time (sec)
khydrolysis (sec-1)
0.010
0.029
+– 0.004
+– 0.0001
pH
6.5
7.0
t1/2 (sec)
69
24
1M7 hydrolysis in LB medium
A
B C
Figure 3.1 SHAPE chemistry conditions are condicive to cellular conditions (A) Sche-
matic of the mechanism of SHAPE chemistry (B) Effect of DMSO concentration on E. coli 
growth rate. (C) Pseudo-first order hydrolysis of 1M7 in Luria Broth (37 °C) at pH 6.5 (circles) 
and pH 7.0 (squares), correspsonding to that of the culture media at the beginning and mid-log 
phases of cell growth.  For clarity, every fifth data point is shown.
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Figure 3.2 In vivo SHAPE. (A) Schematic of the in vivo SHAPE protocol. (B) 
Electropherogram resulting from in vivo SHAPE.  Reactions performed in the presence and 
absence of 1M7 (blue and green, respectively).  Dideoxy sequencing (ddC) (black trace).  (C) 
Histogram of normalized SHAPE reactivities and superposition on 16S rRNA. 
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Figure 3.3 In vivo absolute 2'-hydroxyl reactivities superimposed on the E. coli 16S 
structure determined by comparative analysis. Areas shaded in grey are indicative of 
agreement of SHAPE data with the phylogenetic structure. Boxed helices indicate areas 
where the SHAPE data is in disagreement with the phylogenetic structure. 
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Figure 3.4 In vivo absolute SHAPE reactivities for the 16S rRNA after inhibition of 
transcription superimposed on the E. coli 16S secondary structure.  Transcription was 
halted by treatment with rifampicin.  Nucleotides that significantly decreased or increased in 
SHAPE reactivity due to arrest of transcription are highlighted in blue and orange, 
respectively. Boxed helices are colored as in Figure 3.3. 
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Figure 3.5 Nucleotides with differential reactivity in the presence and absence of 
transcription. (A) Number of rifampicin-responsive nucleotides over 50-nt windows. (B) 
Rifampicin-responsive nucleotides highlighted on the structure of each of the domains of the 
16S rRNA (PDB no. 3I1M). Number of nucleotides with differential SHAPE reactivity 
contained in each domain is given in blue and the total nucleotides probed in the domain are 
given in grey.  Domains are separated along the x-axis (dotted line) in space. 
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Figure 3.6. Rifampicin-responsive nucleotides are involved in higher-order structural 
interactions. RR-nts are highlighted as spheres that participate in RNA-RNA inter-domain 
interactions (green), RNA- 30S protein interactions (yellow), and intersubunit interactions 
(purple) on the three-dimensional structure obtained from crystallographic analysis (PDB no. 
3I1M). (A) Domains are separated along the x-axis in space (dotted line). (B) Helical 
elements that do not appear to form in the steady-state structure are highlighted in magenta.  
Helical elements predicted to locally refold during incorporation of 16S rRNA into 
ribosomes are highlighted in cyan. 
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Figure 3.7  Helical elements predicted to not form (magenta) or to locally refold (cyan) 
in the steady-state in vivo 16S structure displayed on the 3D model of the 30S subunit 
(A) without proteins and (B) with late binding proteins (S2,S3,S5,S10,S12, and S21), colored 
yellow and shown in a surface representation. On the left, the 30S is viewed from the 50S 
interface. On the right, the 30S is viewed from the solvent side 
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CHAPTER 4 
 
Identification of an RNA secondary structure switch in vivo:  30S subunits 
must switch from “inactive” to “active” in live cells 
 
4.1 Introduction 
 The ribosome is the ribonucleoprotein complex responsible for all protein synthesis 
in living cells.  The 70S bacterial ribosome is composed of a large subunit (50S) and a small 
subunit (30S) (1, 2).  The large subunit is made up of 33 ribosomal proteins and two 
ribosomal RNAs (rRNAs), the 23S rRNA of 2,904 nucleotides and the 5S of 120 
nucleotides. The small subunit contains 21 proteins and the 16S rRNA, which is 1,542 
nucleotides in length.   
The ribosome catalyzes peptide bond formation directed by a messenger RNA 
(mRNA) template in a highly accurate, fast, and dynamic process called translation.  The 
process of translation occurs in four stages: initiation, elongation, termination, and 
recycling.  In the initiation phase of translation, the 30S subunit binds to the start codon on 
the mRNA and associates with the 50S with the help of three initiation factors (IF1, IF2, and 
IF3) (1, 3).  During the elongation cycle, amino acids are progressively added to the 
growing peptide chain as the mRNA is decoded. Termination occurs when the stop codon of 
the mRNA is reached; at this stage the nascent peptide chain is released.  Finally, in the 
recycling phase, the ribosome releases the bound mRNA, deacylated tRNA, and the subunits 
become dissociated, preparing the subunits for a new round of protein synthesis..   
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Throughout the stages of translation, the 30S subunit undergoes both large and small 
conformational changes.   Most of what we know about the conformational dynamics of the 
ribosome comes from high-resolution structural studies and biochemical probing 
experiments performed under high magnesium conditions in vitro (1, 3).   
 In the cell, the magnesium concentration is low, ~1 mM Mg2+ (Tyrrell et. al, in 
preparation).  Therefore, despite the enormous value of these experiments, questions remain 
as to whether the structures observed in vitro accurately mimic the structures that occur in 
live cells.  For example, the 30S subunit has been observed in two conformational states in 
vitro: 1) “active” state requires 30S subunits to be heated at high magnesium concentrations 
at 42 °C before they will optimally bind tRNA and mRNA (4).  2) the “inactive” state is not 
heated under these conditions and does not bind tRNA and mRNA efficiently (4).  Without 
direct in vivo probing, it is difficult to know if either conformational state is biologically 
relevant. 
In this chapter, I demonstrate that in vivo SHAPE can be used in conjunction with 
sucrose density gradient sedimentation to separate ribosomal components after in vivo 
SHAPE modification.  I herein report the SHAPE analysis of the 16S rRNA in two different 
functional states; first, while part of the free 30S subunit and second, while part of a 
translating 70S ribosome.  My analysis will show that the two structures are very different 
and require a change in secondary structure to intra-convert between the two. Finally, I will 
show evidence that both structures are relevant to in vivo ribosome function. 
 
4.2 Results 
4.2.1   Sucrose density gradient sedimentation separates ribosomal components after 
in vivo SHAPE modification 
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As discussed in Chapter 3, the steady-state RNA structure of the 16S rRNA is very 
dynamic and exhibits a large degree of structural heterogeneity.  SHAPE reactivity data 
collected over a short time window will therefore reflect the average structural state present, 
a factor that would confound accurate structure determination in context of ribosome 
function.  
To solve this problem, I first used in vivo SHAPE to modify ribosomes in distinct 
functional conformations in live E. coli cells, then halted translation by rapidly pouring the 
cells over ice, and finally separated the different ribosomal components (30S, 50S, 70S, and 
polysomes: multiple ribosomes on the same message) active in the cell at the time of 
modification by velocity sedimentation through a linear sucrose gradient (5).  Velocity 
sedimentation and subsequent fractionation allows for specific ribosomal particles to be 
analyzed. 
Fractionation of the sucrose gradient requires monitoring of the absorbance at 260 
nm to identify the fractions containing ribosomes.  Since the hydrolysis product of 1M7, 2-
methylamino-4nitrobenzoate, absorbs strongly at 254 nM, it was first removed by passing 
the cell lysate through a pd-10 desalting column before velocity sedimentation was 
performed..  
A typical absorbance profile after in vivo SHAPE modification is shown in Figure 
4.1A.  Ribosomal components were successfully separated. The profile resulting from cells 
treated with 1M7 is consistent with the profiles resulting from cells grown under the same 
conditions but not treated with the reagent (data not shown).  Peaks corresponding to 
polysomes (Figure 4.1A) were observed indicating that our modified polysome purification 
method is gentle enough to not shear the mRNA. Ribosomes isolated in the polysome peak 
were actively involved in translation at the time of modification.  The 70S peak is most 
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likely made up of free 70S ribosomes and some 70S ribosomes that finished translating after 
modification and “ran-off” the message.  The other two smaller peaks (30S and 50S) 
represent subunits waiting to enter the translation cycle, either from assembly or 70S 
recycling.  
 
4.2.2 In vivo SHAPE analysis of the 16S rRNA in free 30S subunits and translating 
ribosomes 
The fractions corresponding to polysomes (4+) were pooled. The fractions 
corresponding to 30S free subunits were also pooled. For each sample, the proteins were 
removed, the rRNA isolated, and primer extension was used to identify the nucleotides of 
the 16S rRNA modified with 1M7 in vivo.  The resulting SHAPE reactivities are shown on 
the E. coli 16S secondary structure in Figure 4.1B and C.    
We compared the SHAPE data for the 16S rRNA when in free 30S subunits to that 
when incorporated into actively translating ribosomes.  Most nucleotides (~94%) did not 
exhibit significantly different SHAPE reactivities (within 0.3 SHAPE units).  Some 
nucleotides exhibited significant decreases in SHAPE reactivity (greater than - 0.3 SHAPE 
units), in polysomes than in the 30S.  This implies these nucleotides are stabilized by 
interactions that occur on the 70S ribosome but not the free 30S subunit. Many of these 
changes in nucleotide dynamics can be explained by known interactions that occur during 
translation, such as subunit association and binding of the ligands, tRNA and mRNA (6-9).  
For example, nucleotides 702 and 703 are reactive in the 30S, but unreactive in polysomes.  
This is consistent with the formation of the intersubunit bridge, B7a, between the 30S and 
the 50S subunits (10).  Another example is that the nucleotides in the 790 loop are reactive 
in the 30S subunit, but unreactive in polysomes.  These nucleotides form part of the P-site in 
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the ribosome.  That these nucleotides become less accessible to SHAPE reagent in the 
polysomes is consistent with tRNA occupancy of the P-site in translating polysomes. 
Most of the nucleotides that are more flexible in the free 30S and then become 
constrained in polysomes are in loops and bulges.  This observation is consistent with the 
formation of tertiary structure interactions and is similar to structural changes observed by in 
vitro by chemical probing (6, 11).  In 43 out of the 45 helices in the 16S rRNA in free 30S 
subunits, the SHAPE reactivities are consistent with the conventional RNA secondary 
structure.  Thus, it is unlikely that the RNA structure in these regions undergoes any large-
scale secondary structure rearrangements in the translating ribosome compared to the free 
30S subunit.   
 
4.2.2  Identification of an in vivo RNA secondary structure conformational change in 
the 16S rRNA between free 30S subunits and the 70S ribosome  
 One region was identified that contains nucleotides with significant differences in 
SHAPE reactivity between the 30S subunit and polysomes (Figures 4.1B, C, insets). These 
nucleotides occur within a helical element in the accepted 16S rRNA secondary structure 
and cannot be easily explained by existing biochemical data.  This region is composed of the 
first half of helix 28 (h28) and the upper part of helix 44 (h44) and is adjacent to the 
decoding region of the 30S.  In this region, the SHAPE profile for the 16S rRNA in 
polysomes is largely unreactive with only nucleotide 1397 exhibiting moderate flexibility 
(Figure 4.1D, top).  In contrast, the SHAPE profile for the 16S rRNA in free 30S subunits 
indicates the nucleotides in this region are flexible (Figure 4.1C, bottom); nucleotides 1390, 
1392, 1394, and 1399 are highly reactive, and 1391, 1393, 1397, 1398, and 1400 are 
moderately reactive.  
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 In the conventional secondary structure model, helix 28 involves base pairing 
between nucleotides 1390-1393 and nucleotides 927 and 925-923. The in vivo SHAPE data 
for the polysomes is consistent with this secondary structure (Figure 4.1B, inset). In 
contrast, the in vivo SHAPE data for the 30S subunit indicates that nucleotides 1390-1394 
are very flexible in the free 30S (Figure 4.2A), suggesting that they are not constrained by 
base-pairing interactions.  These data indicate that these nucleotides must undergo a 
significant change in dynamics at some point during the translation cycle. 
 
4.2.3 Experimental SHAPE reactivities in the region  of helix 28 are consistent with 
an alternative model for the 16S rRNA structure in free 30S subunits 
 Recently collected data suggests an alternate base-pairing model for helix 28 based 
on SHAPE data for the protein-free 16S rRNA (Zhang et al., unpublished results).  In the 
alternate model of helix 28 (aH28), nucleotides 921-927 are predicted to form base pairs 
with nucleotides 1408-1402, and nucleotides 1390-1401 are predicted to form a loop.  
Interestingly, there is evolutionary support for this model.  The experimental in vivo SHAPE 
reactivities for the 30S were superimposed onto the conventional and alternate models for 
helix 28 (Figure 4.2A, and B, respectively).  The in vivo SHAPE data for the 30S is 
consistent with the alternate base-pairing model; almost all the nucleotides predicted to form 
a loop are reactive, and almost all the nucleotides predicted to be base paired are unreactive.   
In an effort to quantify how well the in vivo 30S SHAPE data fits each model, the 
pseudo-free energy change term, ΔGSHAPE, was calculated for each model (12, 13). 
Essentially, this term imposes an energetic penalty when a reactive nucleotide is predicted to 
be base paired and an energetic bonus when an unreactive nucleotide is predicted to be base 
paired.  For the conventional and alternate models, the calculated ΔGSHAPE values are -26.5 
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kcal/mol and -28.5 kcal/mol, respectively.  The ΔΔGSHAPE [ΔG (alt) – ΔG (conv)] is -2.0 
kcal/mol, confirming that the in vivo 30S SHAPE data is more consistent with the 
alternative model than the conventional model.  Thus, the free 30S peak contains 30S 
subunits that, on average, form an alternative secondary structure that switches to the 
conventional secondary structure upon incorporation into translating ribosomes. 
 
4.2.4 The measured SHAPE reactivities of 16S rRNA in the free 30S do not result 
from artifacts of the purification process 
 The free 30S peak of the polysome profile likely represents a mix of recycled 30S 
and newly assembled 30S subunits waiting to enter into the elongation phase of translation.  
Therefore, it is likely that the alternative structure we propose is necessary during the 
initiation step of translation.  Since there is a lag between the time when cells are modified 
and when the ribosomes are separated, there is a chance that the 30S subunits fraction is 
contaminated.  Two of the most likely contaminants are: (1) immature 30S subunits that 
were modified by 1M7 and then finished assembling and (2) 70S ribosomes were modified 
but dissociated during the purification process to sediment in the 30S peak. 
 To ensure that the measured SHAPE reactivity of rRNA in 30S subunits is not 
representative of incompletely assembled 30S subunits when modified by 1M7, cells were 
incubated with rifampicin for 20 minutes to halt transcription, and time was allowed for 
immature 30S species to assemble into ribosomes before modification with 1M7.  The 
polysome profile was obtained as described.  Histograms of SHAPE reactivities for the in 
vivo free 30S peak resulting from the native preparation or that after transcription was halted 
are shown for nucleotides 1375-1420 in (grey and purple, Figure 4.2C (grey and purple). 
Absolute reactivities for the 16S rRNA in free 30S subunits after transcription was halted 
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were almost identical to those obtained when no drug was added (Pearson’s linear r = 0.92). 
Therefore, it is unlikely the SHAPE reactivity profile we observe for 16S rRNA in free 30S 
subunits, and thus the alternative base-pair structure, does not result from an immature 30S 
species. 
 Although rapidly chilling cells significantly slows elongation, it does not fully 
prevent 70S ribosomes from finishing translation and “running” off the mRNA.  These “run-
off” 70S ribosomes are empty (no tRNA or mRNA bound), and subunits can dissociate (11). 
To ensure that 70S ribosomes did not dissociate into 30S and 50S subunits after 
modification by 1M7 during the purification process, the antibiotic chloramphenicol was 
added to cells to stabilize 70S ribosomes before treatment with 1M7.  Chloramphenicol 
binds to the 50S subunit and prevents the peptidyl transfer reaction from occurring; this in 
turn prevents translocation, stabilizing the ribosome on the mRNA and preventing 
dissociation (14). Histograms of the SHAPE reactivities for the in vivo free 30S peak 
resulting from the native preparation or after translation was halted are shown for 
nucleotides 1375-1420 in Figure 4.2D (grey and dark blue).  The absolute reactivities are 
nearly identical (Pearson’s linear r = 0.90).  Experiments were also performed where cells 
were treated with both rifampicin and chloramphenicol (data not shown).  No significant 
differences in SHAPE reactivity for the 30S were observed under these conditions. 
Together, these data indicate that the SHAPE reactivity profile we observe for 16S rRNA in 
free 30S subunits is not biased by contaminating forms. 
 
4.2.5 The in vivo 16S rRNA structure in 30S subunits resembles structure in inactive 
30S subunits in vitro 
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 We next compared the in vivo 16S rRNA structure to two distinct 30S states in vitro.  
In vitro experiments have previously revealed that free 30S subunits must be heated at high 
Mg2+ concentrations (20 mM) at 42 °C to optimally bind tRNA and mRNA to be used in in 
vitro translation assays (4).  The state post this treatment has traditionally been referred to as 
“active”, whereas 30S subunits not heated under these conditions are referred to as 
“inactive”.  Previous chemical probing studies identified nucleotides 1391-1393 in helix 28 
as more accessible to DMS in “inactive” 30S than in “active “ 30S subunits (15).  Since 
these data are consistent with the in vivo 30S conformation, it is possible that the inactive 
30S structure represents an authentic in vivo state. 
 Purified 30S subunits were probed in vitro under “active” and “inactive” conditions 
(see Methods).  The resulting SHAPE reactivities for nucleotides 1385-1425 are shown 
superimposed on those obtained for 16S rRNA from in vivo free 30S subunits in Figure 
4.3A and B for inactive and active subunits, respectively.  Comparison of the SHAPE 
reactivities reveal that nucleotides in this region exhibit very different SHAPE reactivities 
(Pearson’s linear r=0.55).  Significantly, the mean SHAPE reactivity of nucleotides 1390-
1394 from 16S rRNA isolated from the active subunits is only 0.2 SHAPE units and only 
G1392 is moderately reactive.  This is consistent with these nucleotides being constrained 
by base-pairing interactions and inconsistent with formation of a flexible loop.  The 
experimental SHAPE reactivities for 16S rRNA from the in vitro active 30S are 
superimposed on the conventional and alternate structure models in Figures 4.3C and D (left 
panels). The SHAPE reactivities are more consistent with the conventional base pairing 
(ΔGSHAPE= –30.9 kcal/mol) that the alternative base-pair model we proposed for the rRNA 
probed in 30S subunits in vivo (ΔGSHAPE= –29.0 kcal/mol).   
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 The SHAPE reactivities for the 16S rRNA from in vitro inactive 30S subunits are 
very similar to those of the rRNA probed in 30S subunits in vivo (Figure 4.3B, Pearson’s 
linear r=0.93) and are more consistent with the alternate (ΔGSHAPE= –26.7 kcal/mol) rather 
than the conventional (ΔGSHAPE = –25.3 kcal/mol) secondary structure model (Figure 4.3C, 
D, right panels).  These data support the hypothesis that the “inactive” to “active” 
conformational switch requires an RNA secondary structure change in helices 28 and 44 of 
the conventional model. 
 
4.2.6 Stabilization of helix 44 shifts the inactive conformation of 16S rRNA towards 
the active conformation 
 Our data indicate that 16S rRNA must undergo a significant structural rearrangement 
before the 30S subunit can participate in translation.  In vitro, this structural rearrangement 
only occurs in the presence of high magnesium (20 mM Mg2+) and heat ( 42 °C)..  Since the 
magnesium concentration in vivo is ~1 mM (Tyrell et al, in progress) and cells grow at 37 
°C, translation factors likely “activate” the in vivo 30S subunit.  It is unlikely that there is a 
large activation energy required to switch between the two 16S rRNA structures.   
Paromomycin is an aminoglycoside that binds to the bulge of helix 44 formed by 
A1408, A1492, and A1493, which is directly adjacent to aH28 (8, 16).  This antibiotic 
stabilizes helix 44 and has been shown to stimulate subunit association at low 
magnesium(17). Since the rRNA in the 70S ribosome is in the conventional structure,  we 
hypothesized that binding of paromomycin might shift the equilibrium of the 16S rRNA 
towards the conventional structure.  We incubated inactive 30S subunits with paromomycin 
at 15 °C in 0.5 mM Mg2+ buffer.  The resulting SHAPE reactivities were compared to those 
of 16S rRNA from inactive and active 30S subunits (Figure 4.4). The average SHAPE 
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reactivity of nucleotides 1390-1394 decreased from 0.63 to 0.26 when paromomycin was 
incubated with inactive 30S subunits.  This is consistent with the hypothesis that stabilizing 
h44 induces a shift in the structure equilibrium towards the conventional secondary 
structure.  In fact, the ΔGSHAPE for the conventional (–29.8 kcal/mol) base pair model is 
lower than the ΔGSHAPE for the alternative model (–28.3 kcal/mol) when the reactivities of 
the 16S rRNA from inactive 30S subunits incubated in paromomycin are compared in this 
fashion. 
 
4.2.7 Stabilization of helix 28 decreases translation activity 
 The data presented thus far strongly support the hypothesis that structure in the 
h28/h44 region of the 16S rRNA in free 30S subunits in vivo is not the same as the structure 
of the RNA in translating ribosomes.  Additionally, the data imply that there is not a large 
energy difference between the two 16S rRNA conformations.  It is likely, therefore, that the 
alternative base-paired structure is important for in vivo 30S function, and that the 30S needs 
to be able to switch between the two structures.  To more directly test this hypothesis, I 
designed a series of mutations in helix 28. In collaboration with the Fredericks lab at OSU, 
16S rRNA mutations were assessed using a specialized ribosome system that allows the 
effects of 16S rRNA mutations to be quantified without affecting the cell growth (18).  
Overall translation activity (as measured by β-galactosidase activity) was assessed as well as 
the rate of spurious initiation from a non-AUG start codon (Table 4.1). 
  Two sets of mutations were designed.  The first was designed to stabilize the 
conventional base pairing pattern of helix 28 without affecting the stability of helices in the 
alternate model.  The second set of mutations was designed to destabilize the base pairs in 
this region of the alternative model, shifting the equilibrium towards the conventional base 
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pairs.  None of the nucleotides mutated participate in any known direct interactions with 
ligands.   
The first three mutations (Table 4.1) were designed to increase the stability of the 
conventional h28 by mutating the two G-U base pairs to G-C base pairs.  These mutations 
should have a limited effect on the stability of the alternate structure since U1390 and 
U1391 are predicted to be single stranded.  The effects of mutating each G-U base pair to a 
more stable G-C base pair were first assessed individually (U1390C, U1391C) and then 
together (U1390C/U1391C).  All of these mutations significantly impacted translation as 
summarized in Table 4.1.  The single mutation U1390C decreased β-galactosidase activity 
by 31%, and a much stronger result was observed with the U1391C mutant, which 
decreased translation to only 1.6% of wild-type activity.  Surprisingly, the double mutant 
(U1390C/U1391C) restored activity slightly, although β-galactosidase activity was still less 
than 10% of wild-type levels.  An attempt was made to “re-loosen” h28 with the triple 
mutant (U1390C/U1391C/C1395U), which reintroduced a G-U base pair into the helix.  
This mutation further decreased translation.  The mutant C1395U was characterized 
previously (#CITE Thomas 1988) and was shown to have a very detrimental effect on 
translation. Thus, it is likely that this nucleotide is important for reasons in addition to 
stabilization of helix 28 and was not a good choice to include in our experiment.  In sum, the 
data show that stabilizing the conventional helix 28 leads to a decrease in translation. 
The last three mutations were designed to destabilize the proposed alternative helix 
28 by introduction of a mismatch.  Based on the structural models, the double mutation 
A923C/U1393G should stabilize the conventional model by replacing an A-U pair with a 
stronger C-G pair but should destabilize the alternative helix by replacing an A-U pair with 
a mismatch between 923-1406.  A strong reduction in translation was observed with the 
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A923C/U1393G mutation (>90%).  Next, we designed a double mutant (A923U/U1393A) 
expected to disrupt the alternative helix without altering the relative stability of the 
conventional h28 (replacing an A-U with a U-A.  Again, a strong reduction in translation 
was observed (>80%).  Interestingly, this mutant exhibited a fidelity phenotype greater than 
that of the wild type.  We attempted to restore the equilibrium between the two structures 
with a triple mutant (A923U/U1393A/U1406A) that, in context of the alternate model, 
should restore the A-U base pair previously disrupted.  However, translation efficiency was 
not restored and, in fact, dropped to 11% of the control.  Interestingly this mutant was 
severely defective in initiation fidelity (12-fold decrease).  Nucleotides A1408 and A1410 
have been shown to be important for IF1 binding (19), so it is possible that a direct 
interaction was disrupted.  In sum, the data show that mutations that destabilize the 
alternative structure significantly decrease translation efficiency.  Because the compensatory 
mutation did not restore function; however, it is difficult to know whether mutations were 
deleterious due to disrupting the alternative helix or through disruption of a currently 
uncharacterized interaction. 
 
4.2.8 Evidence for the alternatively base-paired structure in 16S rRNA mutant 
A923U/U1393A 
 Although the mutation data implies that the proposed alternative secondary structure 
is important for translation, it is difficult to fully interpret these results in context of the two 
structural models.  Therefore, we used in vivo SHAPE to probe the structure of the double 
mutant A923U/U1393A to assess whether this mutation influenced the structural 
equilibrium.  With the help of the Frederick lab, a plasmid containing the double mutation 
A923U/U1393A was moved into a Δ7prrn strain of E. coli that lacks all chromosomal rRNA 
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operons (19).  The only ribosome operon expressed is from the plasmid, thus insuring a 
homogenous population of ribosomes.   
The wild-type and mutant Δ7prrn cells were grown to mid-log phase and probed by 
SHAPE in vivo.  The resulting SHAPE reactivities of nucleotides 1385-1425 of the 16S 
rRNA from the free 30S subunit are shown in Figure 4.5A and the SHAPE difference plot of 
reactivities of wild-type and mutant 16S rRNA as shown in Figure 4.5B.  The wild-type 16S 
rRNA exhibits a SHAPE reactivity pattern consistent with the alternate base-pairing model; 
nucleotides 1390-1401 are reactive, and nucleotides 1402-1408 are unreactive to SHAPE 
chemistry in vivo. The experimental SHAPE reactivities for the wild-type 16S rRNA are 
much more consistent with the alternate (ΔGSHAPE= –22.7 kcal/mol) than the conventional 
(ΔGSHAPE = –18.5 kcal/mol) model (Figure 4.5C, D, left panels) with a difference between 
the two of –4.2 kcal/mol. These data are consistent with the SHAPE data obtained in the 
DH5α strain, which has all seven rrn operons, although there are some small differences.  
For example, nucleotides 1394-1395 were reactive in vivo in the Δ7prrn strain, but 
unreactive in the DH5α strain.  This could be indicative of more structural heterogeneity in 
the DH5α strain, most likely due to transcription of the seven operons at different times.  
If the double mutation disrupts the alternative helix, then the mutant 16S rRNA 
should be more likely to form the conventional structure than the alternate structure.  Thus, 
we would expect to see a significant decrease in SHAPE reactivity for nucleotides 1390-
1396 that are single stranded and an increase in SHAPE reactivity for the nucleotides 1402-
1408 that are base-paired in the alternate model.  The differential SHAPE analysis (Figure 
4.5B) clearly shows the expected trend: nucleotides 1390-1396 are less flexible by a mean 
SHAPE reactivity decrease of 0.34 SHAPE units. Conversely, nucleotides 1403-1408 are 
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more flexible in the mutant by 0.3 SHAPE units than in the wild-type rRNA.  Significantly, 
the experimental SHAPE data for the mutant fit the conventional model (ΔGSHAPE= – 16.4 
kcal/mol) almost as well as the alternative model (ΔGSHAPE= –17.1 kcal/mol).  These data 
are consistent with the double mutation driving the structural equilibrium towards the 
conventional base pairing model.  Therefore, the alternative structure we have proposed 
exists in vivo. 
 
4.3 Discussion 
4.3.1 Expansion of in vivo SHAPE as a methodology for understanding RNA 
structure and dynamics in the cell 
 With in vitro experiments, scientists strive to replicate in vivo conditions in a test 
tube.  Because the cellular environment is so complex, this is a nearly impossible task.  
Questions almost always remain about whether structures or functions observed in vitro are 
accurate representations of those that occur in vivo.  Therefore, probing the structure of an 
RNA in the cellular environment is of the utmost importance for understanding how an 
RNA functions in live cells.   
One of the limits of using traditional chemical probes in vivo has been that 
quenching the excess reagent requires treating cells with harsh reagents such as 2-
mercaptoethanol and isoamyl alcohol; these reagents almost certainly disrupt fragile cellular 
complexes including some RNA-protein interactions (20).  This makes chemical probing 
almost impossible to use in conjunction with traditional molecular biology techniques to 
isolate specific RNA states and makes interpretation of the data difficult.   
The SHAPE chemistry invented in our lab does not suffer from limitations of typical 
chemical probes. I successfully modified RNA using the SHAPE reagent 1M7 in growing 
cells and then separated ribosomal particles with sucrose density gradient sedimentation.  
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The sedimentation profiles show that these particles are intact, meaning that SHAPE does 
not disrupt RNA-protein interactions in vivo.  Further, I was able to isolate the fragile 
polysomes, demonstrating that SHAPE did not disrupt these cellular complexes. 
 
4.3.2 The inactive 30S conformation is a biologically relevant state  
 Using in vivo SHAPE followed by gradient fractionation of ribosomal complexes, 
we were able to examine the 16S rRNA structure in free 30S subunits and in polysomes 
actively translating mRNA.  The secondary structure of the 16S rRNA when incorporated 
into polysomes was consistent with data from previous high-resolution studies (21).  
Conversely, the rRNA in the free 30S subunit did not resemble the structure proposed based 
on covariation(22) and biochemical probing of the 16S rRNA in 30S subunits performed in 
vitro (Figure 4.3A).  This is because most in vitro probing studies were performed on 30S 
subunits that had been heated in the presence of high concentrations of magnesium.  Instead, 
the 16S rRNA probed in vivo in free 30S subunits most closely resembled the conformation 
of the rRNA in the “inactive” 30S subunit (Figure 4.3B).  The inactive 30S state does not 
efficiently bind tRNA (23) and has been assumed to be an artifact of purification. My in vivo 
SHAPE results suggest that the inactive 30S conformation is biologically relevant. 
 
4.3.3 The 16S rRNA in inactive 30S subunits and in free 30S subunits in vivo have 
similar structures  
 Most of the in vivo SHAPE data for the 16S rRNA from free 30S subunits is 
consistent with the conventional secondary structure (Figure 4.1B, left panel).  However, we 
identified one region where the experimental SHAPE data is inconsistent with the 
conventional secondary structure (Figure 4.2A).  In this region, the data was consistent with 
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an alternatively base-paired structure first identified in the protein-free 16S rRNA (Zhang et 
al, unpublished results).  In the alternative structure (Figure 4.2B), a helix is formed between 
nucleotides 921-927 and 1402-1408, and nucleotides 1390-1401 are single-stranded.  The 
SHAPE data for rRNA from the in vitro inactive 30S is also consistent with this alternative 
structure (Figure 4.3D, right panel).  
To test this alternate model, we used site-directed mutagenesis and evaluated activity 
of mutant 16S rRNA in E. coli cells (Table 4.1).  In general, mutations designed to stabilize 
the conventional base pairs were deficient in translation activity.  However, we were not 
able to restore functionality with compensatory mutations. Although the nucleotides that 
were mutated are not directly involved in known functional interactions, they are adjacent to 
important sites, making interpreting the mutational data only in context of the structural 
models difficult.   
To examine the structures of one of the mutations, A923U/U1393A, more directly, 
we used in vivo SHAPE.  Although this mutation introduces an approximately isoenergetic 
U-A base pair for the existing A-U base pair, we hypothesized that the mutation would shift 
the equilibrium towards the conventional structure by introducing a U-U mismatch into the 
unique helix in the alternate model.  The double mutant had decreased SHAPE reactivity in 
nucleotides 1390-1394 and increased SHAPE reactivity at nucleotides 1402-1408 compared 
to the wild-type rRNA (Figure 4.5A, B).  Since nucleotides 1390-1394 become much less 
reactive than those in the wild-type rRNA, we concluded that the equilibrium did in fact 
shift towards the conventional structure (Figure 4.5C, D).  As nucleotides 1402-1408 
become more reactive in the mutant, we concluded that nucleotides 921-927 are 
predominantly base paired to 1408-1402 (the alt-28 conformation) in the 16S rRNA in the 
free 30S complex in vivo. 
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4.3.4 The alternative model is consistent with previous structural investigations of the 
inactive 30S in vitro 
 Previous chemical probing studies on the inactive 30S in vitro indicated that h28 and 
part of the adjacent h44 are disrupted in the inactive state (15), and studies suggest that this 
affects the ability of the 30S subunit to bind tRNA (24).  Our SHAPE results are largely 
consistent with the DMS probing data (15). However, nucleotides 923-927 are slightly more 
reactive towards DMS in the inactive subunit than in the activated 30S, but our data imply 
that these nucleotides are constrained (Figure 4.3C, right panel). Based on psoralen 
photochemical cross-linking, it was hypothesized that nucleotides 921-923 were base paired 
to 1532-1534 (23); however, subsequent mutational analysis proved that this was unlikely as 
the inactive state forms when nucleotides 1534-1542 are deleted (24).  These data are, 
however, consistent with the model presented here.  Molecular modeling of the alternative 
helix (Zhang et al, unpublished results) shows that formation of the alternative helix 
necessitates a change in accessibility of the 3$ end of the 16S rRNA.  In agreement with 
psoralen photochemical cross-linking, nucleotides 921-923 and nucleotides 1532-1534 are 
likely close in space, although not base paired.  
 
4.3.4 Biological implications of the alternative base pairs in the inactive state 
 We have long known that translation is a dynamic process.  Recently several 
conformational changes have been identified by comparison of high-resolution structures of 
ribosomes during elongation and termination (25).  These changes are in tertiary structure 
(i.e., helix movement) or in conformations of individual nucleotides.  For example, during 
inter-subunit rotation, helix 44 moves ~6Å (26).  An example of a specific change in 
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nucleotide conformation is that binding paromomycin to the 70S subunit causes nucleotides 
1492 and 1493 to extrude out of helix 44 (8).  Until now, no significant conformational 
change in RNA secondary structure had been detected once the 30S subunit was fully 
formed. 
 Here we identified an alternate conformation of the h28/h44 region that exists in the 
16S rRNA in the free 30S subunit in vivo.  The 16S rRNA structure in 70S ribosomes 
actively translating the mRNA was consistent with the conventional structure. This 
conformational difference is likely similar to that between active and inactive 30S subunits 
in vitro.  We propose that the alternate structure of 16S rRNA is characteristic of the 
“resting” state of the 30S subunit.  We propose that during the initiation step of translation, 
the 16S rRNA undergoes a conformational change to the conventional structure.  
Conversely, after the ribosome has finished translation of the mRNA (termination), the 16S 
rRNA undergoes the reverse conformational change from the conventional structure to the 
alternative structure during recycling.  This model is shown in Figure 4.6 and is consistent 
with the known kinetics of translation (27).  Although elongation is a very fast process 
(~0.1-1 second per codon), recycling and initiation occur at a much slower rate.  
Significantly, initiation is the rate-limiting step of the translation process.  We propose that 
this may be due to the necessity for reorganization of the 16S rRNA secondary structure.   
 The alternative conformation seems to be necessary for in vivo function.  When 
mutations were made that stabilized the conventional model, overall translation activity 
decreased significantly (Table 4.1). If the alternative conformation was not necessary for 
translation in vivo, then the double mutation (A923U/U1393A) designed to shift the 
structural equilibrium towards the conventional structure should have had a minimal effect 
on translation activity.  However, translation activity of this mutant decreased by over 20% 
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compared to that of the wild-type system.  This implies that the alternative conformation is 
necessary for in vivo ribosome function.   
 Since correct tRNA selection is critical during initiation, the alternative structure 
may be important during the initial proofreading.  Our data suggest that this is not the case 
since the double mutant had a 2-fold increase in fidelity for AUG start codons relative to an 
AUC codon.  Additionally, almost all of the mutants that stabilized the conventional 
structure had a higher fidelity phenotype (Table 4.1).  Thus, the alternative structure seems 
to be crucial for turnover, but not for fidelity.   
 
4.3.5 Summary 
 In sum, I have used in vivo SHAPE to determine that the structure of 16S rRNA in 
the free 30S subunit is not identical to that in translating ribosomes.  The conformation of 
the 16S rRNA in the free 30S subunit more similar to the 16S rRNA in the inactive state of 
the 30S in vitro than in the active state.  Additionally, I have shown that disruption of the 
alternative structure leads to an impairment of translational activity.  This suggests that the 
metastable 30S complex must be “activated” in vivo by translation factors during initiation, 
effectively making the ribosome a riboswitch. 
 
4.4  Experimental 
4.4.1 In-cell SHAPE 
 E. coli cells (DH5α or Δ7prrn) were grown to mid-logarithmic phase (OD600 ~0.6) at 
37 °C.  Cells (200 mL) were added to 6.2 mL 166.67 mM 1M7 (dissolved in anhydrous 
DMSO [3% vol/vol], 5 mM 1M7 final).  Concurrently, a no-reagent control was performed 
omitting 1M7.  Samples were allowed to react with shaking for 2 to 5 min at 37 °C.  The 
cells were rapidly chilled by pouring samples over 150 g of ice, and samples were spun for 
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20 min at 14,000 g at 4 °C in a Sorvall GSA rotor.  Cells were resuspended in ~1 mL lysis 
buffer [20 mM Hepes-KOH (pH 7.8), 0.5 mM MgCl2, 100 mM NH4Cl, 4 mM β-
mercaptoethanol, 16% sucrose], lysozyme (15 µL, 50 mg/mL) was added, and samples were 
incubated on ice for 15 min.  Cell lysis was initiated by freezing the samples in liquid N2, 
followed by thawing in ice water.  The freeze-thaw cycle was repeated twice.  After the last 
cycle, the cells were incubated on ice with 10 µL deoxycholate (15 µg/mL).  Cellular debris 
was removed by spinning 45 min at 24,000 g at 4 °C.   
 
4.4.2 Purification of ribosomal components from SHAPE-treated cells 
 Pd-10 columns (GE Healthcare) were equilibrated with buffer [20 mM Hepes-KOH 
(pH 7.8), 0.5 mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] according to the 
manufacturer’s protocol.  Sucrose sedimentation profiles were performed essentially as 
described(5).  The cleared cell lysate (~2 mL) was loaded onto columns, and columns were 
spun for 2 min at 4,000 g at 4 °C in a swinging-bucket rotor to remove the hydrolyzed 1M7.  
The lysate was then loaded onto a 10-45% sucrose gradient in polysome buffer [20 mM 
Hepes-KOH (pH 7.5), 6 mM MgCl2, 100 mM NH4Cl, 4 mM SH4] and spun in an SW28 
rotor at 40,000 g for 12 hr at 4 °C.  The speed and time were optimized to allow resolution 
of both polysomes and 30S subunits.  Gradients were fractionated (0.5 mL per fraction) 
using a Biocomp Piston Gradient Fractionator with a BIORAD Econo UV Monitor (Abs260 
scale of 1.0).  Fractions corresponding to 30S subunits, 70S ribosomes, and polysomes (four 
or more ribosomes) were pooled and concentrated (Amicon Ultra, 100,000 MWCO, 
Millipore).  RNA was extracted using the Qiagen RNeasy Mini kits according to 
instructions.  RNA concentration was determined by absorbance at 260 nM. 
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4.4.3 In vitro SHAPE modification 
 Escherichia coli DH4α 30S subunits were purified as described (28).  Inactivation 
and reactivation of 30S subunits was done essentially as described (15).  For inactivation, 
30S subunits were incubated at 4 °C in inactivation buffer [20 mM Hepes-KOH (pH 7.5), 
0.5 mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] for 20 min and then at 15 °C for 
15 min.  For activation, 30S subunits were incubated in activation buffer [20 mM Hepes-
KOH (pH 7.5), 20 mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] for 20 min at 42 
°C.  Buffer was added to lower the concentration of magnesium chloride to 10 mM, and 
subunits incubated at 15 °C for 15 min. Paromomycin (2 mM final) or sterile water was 
added, and samples were incubated at 15 °C for 20 min.  After incubation, 45 µL of the 30S 
subunit sample (with or without paromomycin treatment) was added to 5 µL 50 mM 1M7 
(in anhydrous DMSO) and incubated at 15 °C for 10 min.  No reagent control reactions were 
performed by addition of 5 µL neat DMSO.  RNA was extracted using the Qiagen RNeasy 
Mini kits according to the manufacturer’s instructions.  RNA concentration was determined 
by absorbance at 260 nM. 
 
4.4.4 Primer extension 
 Five primers of 19-22 nucleotides were used for analysis of 16S rRNA. The 3$ 
positions of the primers were complementary to 16S rRNA positions 323, 559, 947, 1112, 
and 1492 (29). The DNA primers were 5$-end labeled with either VIC or NED fluorophores 
(Applied Biosystems).  The VIC-labeled primer was used for the (+) or (–) 1M7 channel.  
The NED-labeled primer was used for the sequencing channel.  The modified RNA (1.5 
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pmol) and primer (2 pmol) were mixed and diluted to 13 µL with H2O.  The primers were 
allowed to anneal for 6 min at 65 °C, and then samples were cooled on ice.  Reverse 
transcription buffer [6 µL; 167 mM Tris-HCl (pH 8.3), 250 mM KCl, 10 mM MgCl2, 1.67 
mM each dNTP] and Superscript III (1 µL, 200 units) were added, and samples were 
incubated at 45 °C for 2 min, 52 °C for 60 min, then 65 °C for 5 min.  The reactions were 
quenched with 4 µL 50 mM EDTA.  The cDNAs were recovered by ethanol precipitation, 
washed twice with 70% ethanol, dried at 65 °C for 5 min, and resuspended in 10 µL 
deionized formamide.   
Dideoxy sequencing ladders were produced using unlabeled, unmodified total 
cellular RNA (0.5 mM).  2$,3$-dideoxycytidine triphosphate (1 µL of 5 mM) was added 
before addition of Superscript III. cDNA fragments were separated by capillary 
electrophoresis using the Applied Biosystems 3500 DNA sequencing instrument. 
 
4.4.5  Data analysis 
 Raw capillary electrophoresis traces were analyzed using QuSHAPE (Karabiber et 
al., submitted).  SHAPE reactivities for each experiment were obtained by subtracting the 
no-reagent background integrated areas from the (+) reaction integrated areas.  All datasets 
were normalized by excluding the top 2% of the reactive nucleotides, averaging the next 
10% of reactive nucleotides, and then dividing all intensities by this averaged value.  
Nucleotides with normalized SHAPE reactivities 0-0.3, 0.3-0.7, and >0.7 correspond to 
unreactive, moderately reactive, and highly reactive positions, respectively.  Each 
experiment was performed at least twice, and data were reproducible.  
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Figure 4.1. In vivo SHAPE analysis of ribosomal components. (A) Sucrose density gradient profile 
resulting from cells treated with 1M7 monitored by absorbance at 260 nm.  Peaks of 30S and 50S 
ribosomal subunits, 70S ribosomes, and polysomes containing two to eight ribosomes are indicated. 
Fractions corresponding to the 30S subunits were pooled as were fractions corresponding to polysomes of 
four to eight ribosomes. The 16S rRNA was analyzed by primer extension. (B) Resulting absolute 
SHAPE reactivities from analysis of16S rRNA from 30S subunits are superimposed on the E. coli 16S 
secondary structure. (C) Resulting absolute SHAPE reactivities from analysis of16S rRNA from 
polysomes are superimposed on the E. coli 16S secondary structure. (D) SHAPE reactivities for positions 
1375-1425 of 16S rRNA from polysomes (top) and free 30S subunits (bottom).
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Figure 4.2. Identification of an alternative secondary structure model of 16S rRNA in 
free 30S subunits in vivo. (A) Conventional base-pairing model and (B) SHAPE-supported 
alternative model of 16S rRNA with experimental in vivo SHAPE reactivities from free 30S 
subunits superimposed.  (C) Histograms comparing absolute SHAPE reactivities at 
positions1375-1425 from cells grown without antibiotic (grey), cells grown in rifampicin to 
halt transcription (left, purple), and cells grown in chloramphenicol to halt translocation 
(right, dark blue). 
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Figure 4.3.  Experimental SHAPE reactivities for 16S rRNA in vivo in 30S subunits 
resemble reactivities of 16S rRNA in the in vitro inactive 30S. Histograms comparing 
absolute SHAPE reactivities for 16S rRNA in the in vivo 30S subunits (grey) with 16S 
rRNA reactivities in (A) active 30S (green) and (B) inactive 30S (cyan) subunits. 
Experimental SHAPE reactivities from 16S rRNA from active (left) and inactive (right) 30S 
subunits probed in vitro superimposed on the RNA secondary structure models for the 16S 
rRNA for (C) the conventional and (D) our alternate model 
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Figure 4.4. Paromomycin shifts the 16S rRNA reactivity profile from inactive 30S 
subunits towards the conventional base-pairing pattern. Histograms comparing absolute 
SHAPE reactivities of 16S rRNA from (A) inactive (cyan) and active (green) 30S subunits. 
(B) Histograms comparing absolute SHAPE reactivities of 16S rRNA from inactive 30S 
subunits (cyan) and inactive 30S subunits incubated with paromomycin (purple).  (C) 
Histograms comparing absolute SHAPE reactivities of 16S rRNA from active 30S subunits 
(green) and inactive 30S subunits incubated with paromomycin (purple).  
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Table 4.1 
  
  
16S allele Beta-galactosidase activity1 
Fidelity 
(AUG/AUC) 
Effect on 
stability in 
models 
 
AUG 
Relative AUG 
translation 
activity AUC 
 
Conv Alt 
Control 1250 ± 120 100% 2.4 ± 0.2 600 NA NA 
U1390C 870 ± 20 69% 0.8± 0.04 1100 = N 
U1391C 20 ± 1 1.6% < 0.17 > 200 = N 
U1390C, 
U1391C 110 ± 4 8.8% < 0.17 > 700 =,= N 
U1390C, 
U1391C, 
C1395U 
30 ± 2 2.4% < 0.17 > 200 =,=,o N 
A923C, 
U1393G 110 ± 1 8.8% < 0.17 >700 = X 
A923U, 
U1393A 220 ± 3 18% < 0.17 > 1300 – X 
A923U, 
U1393A, 
U1406A 
140 ± 6 11% 2.8 ± 0.2 50 – – 
1Detection limit is 0.17 units 
NA, non applicable 
N, no effect, in single-stranded region. 
= means a stronger basepair was introduced 
– means an equivalent bp was introduced 
o means a weaker bp was introduced 
X indicates a mis-match 
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Figure 4.5. A double mutation (A923U, U1393A) in 16S rRNA shifts the equilibrium 
towards the conventional structure in vivo. (A) SHAPE histograms comparing wild-type 
(grey) and double mutant (orange) 16S rRNA modified in vivo in free 30S subunits. (B) 
SHAPE difference plot illustrating the effect of the mutations. (C, D) Experimental SHAPE 
reactivities from wild-type (left) and mutant (right) 16S rRNA from free 30S subunits 
probed in vivo superimposed on the RNA secondary structure models for (C) conventional 
and (D) alternate base-pairing models of 16S rRNA. 
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Figure 4.6.  Model of the proposed role of the alternative h28/h44 helix in the 
translation cycle.  The 30S subunit (cyan) is in the in the alternative conformation.  At 
some point during initiation, it undergoes a conformational switch to form the conventional 
conformation (blue) in order to associate with the 50S (purple).  After translation, the 70S is 
recycled, and the 30S structure switches back to the alternative conformation. 
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CHAPTER 5 
In vivo SHAPE analysis of the secondary structure of Kasugamycin bound 
30S subunits reveals a secondary mode of action 
5.1 Introduction 
Kasugamycin (Ksg) is an aminoglycoside antibiotic (1) produced by the bacterium 
Streptomyces kasuganesis (2).  Originally discovered in Japan in the early 1960’s, it is 
currently utilized in the treatment of the fungus Pyricularia orayzae in rice fields (2). In 
vitro, Ksg has been found to inhibit binding of fMet-tRNA to the P site on the 30S subunit 
and 70S ribosomes, but not binding of alanyl-tRNA to the A site (3).  This led to the 
classification of Ksg as a translation initiation inhibitor.  
Recently two crystal structures have been solved identifying the binding sites of Ksg 
on the Escherichia coli 70S ribosome as well as on the Thermus thermophilus 30S subunit (4, 
5).  The primary binding site of Ksg (identified in both structures) is at the top of helix 44 
(h44) on the 30S subunit, where the drug makes direct contact with nucleotides (nts) G926, 
A792, A794, A1499, and U1505 (4).  This binding site is in good agreement with the 
protections observed by earlier biochemical footprinting studies that reported 
dimethylsulfoxide (DMS) protection at A794, G795, and G926 (6). 
 As is the case with many antibiotics, the development of resistance represents a 
serious limitation for widespread use of Ksg.  Understanding the binding behavior of Ksg 
and the mechanism by which resistance to Ksg progresses is essential to understanding the 
behavior of this antibiotic, and may inform the design of similar antibiotics.  
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 In vivo resistance to Ksg can be conferred in two distinct ways. First, mutations to the 
16S rRNA at positions A794 or G926 lead to Ksg resistance (7). Since these residues make 
direct contact with the drug), it is thought that these mutations disrupt the binding site of Ksg 
(4, 5). Second, mutation to, or deletion of, the ksgA gene (8), which encodes for a 
methyltransferase (KsgA), also confers resistance to Ksg in vivo.  KsgA catalyzes the post-
transcriptional dimethylation of N6 of A1518 and A1519 in the loop of helix 45 (9). Ksg 
resistance was attributed to the loss of methylations at nts A1518 and A1519.    However, the 
crystal structures show that these methylations are 5-6.2 Å away from the identified Ksg 
binding site (4).   Given these long distances between the absent methylations and the Ksg 
binding site, it is difficult to rationalize a direct relationship between the binding site and the 
methylations.   The current hypothesis for the mechanism of resistance is that the 
methylations affect the packing of helix 45, which disrupts the binding pocket for Ksg. 
Thus far, mutations that confer Ksg resistance have largely been rationalized by how 
they affect the binding site of Ksg.  However, it has been shown that in vitro, Ksg binds 
mutant ribosomes and inhibits tRNAfMet binding when initiation factors were present (4).  
The incongruity between the in vitro and in vivo data imply that Ksg has another mode of 
action in vivo that has thus far been unobserved in vitro. 
Despite the current breakthroughs in structural characterization of kasugamycin, there 
are a variety of unanswered questions on the mechanisms of this antibiotic in vivo.  Here, I 
report the SHAPE analysis of the 16S rRNA in the presence of Ksg for 70S ribosomes and 
30S subunits.  My analysis will show that Ksg causes a large structural change to occur a 
nearly matured 30S subunit, implying Ksg inhibits a step in the assembly process.  
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5.2 Results  
5.2.1 SHAPE detects kasugamycin binding to active 30S subunits in vitro 
Although SHAPE data are often consistent with traditional chemical probes such as 
DMS, there are sometimes discrepancies due the fact that SHAPE and DMS report slightly 
different structural information about a nucleotide.  DMS reports the accessibility of the base 
nitrogens on A’s,C’s, and G’s (10), while SHAPE ultimately measures local nucleotide 
dynamics (11, 12). To verify that SHAPE was a viable technique to study the effects of KSG 
binding to the ribosome, we initially probed the effect of Ksg binding on local nucleotide 
dynamics in the activated 30S with SHAPE. Upon addition of kasugamycin, nucleotides in 
the 790 loop (U789 and A790) were observed to significantly decrease in SHAPE reactivity 
(data not shown), consistent with the putative Ksg binding site.  No significant changes in 
SHAPE reactivity at nucleotide G926 were detected, likely due to the fact that even in the 
absence of Ksg, this nucleotide is only slightly reactive.  Thus, SHAPE can be used to 
monitor binding of Ksg though the changes in nucleotide dynamics in the 790 loop. 
5.2.2 SHAPE analysis of  the effects of Kasugamycin on ribosome particles in vivo 
To examine the structural effects that kasugamycin has on ribosomes in live E. coli, 
in vivo SHAPE was used to probe DH5α cells (OD600=0.6) that had been incubated with 
kasugamycin (20 min) or sterile water.  Sucrose density gradient sedimentation was then 
used to separate the SHAPE-modified ribosomal particles. 
In contrast to the ribosome profile obtained in the absence of the antibiotic (Figure 
5.1A), no polysomes were detected in the presence of Ksg (Figure 5.1B).  This indicates bulk 
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translation has been inhibited.  Unlike Kaberdina et al., we did not observe any extraneous 
peaks corresponding to protein-deficient 21S or 61S particles upon Ksg addition to cells (13).  
This discrepancy is most likely due to the fact we used a different cell line that is not over-
abundant with leaderless mRNA (13). 
The sucrose gradient was then fractionated.  Fractions corresponding to the 70S 
ribosome and 30S subunit were pooled, proteins removed, and primer extension performed.  
The experimental SHAPE reactivities resulting from the 70S and 30S peak of Ksg-treated 
cells are superimposed on the 16S secondary structure in Figures 5.2A and 5.3A, 
respectively.  For reference, the in vivo SHAPE reactivities from 70S ribosomes and 30S 
subunits of cells not treated with antibiotic are superimposed on a smaller 16S model in 
Figures 5.2B and 5.3B, respectively. 
5.2.3  Kasugamycin induces few structural changes to the 70S ribosome in vivo 
We first assessed the structural changes caused by Ksg on the 70S ribosome. 
Absolute SHAPE reactivities are largely similar in the presence and absence of Ksg for the 
70S in vivo, indicating the global fold of the RNA has not changed upon Ksg addition.  To 
identify the few nucleotides that undergo changes in dynamics when Ksg is added to cells, 
the normalized SHAPE reactivities of the 70S, in the absence and presence of Ksg, were 
directly compared (Figure 5.4A).   
We were unable to directly monitor Ksg binding to the 70S ribosome in vivo through 
the SHAPE reactivities of the 790 loop due to the fact that these nucleotides are unreactive 
towards SHAPE in vivo when no antibiotic is added. None of the nucleotides in the 70S 
ribosome exhibited a significant decrease (greater than 0.3 SHAPE units) in reactivity upon 
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Ksg addition.  However, five nucleotides (U965, C967, A1227, A1229, A1339) exhibited a 
significant increase in SHAPE reactivity (greater than 0.3 SHAPE units) upon Ksg addition 
(Figure 5.4B, red) indicating a significant increase in nucleotide flexibility.  Interestingly, 
these nucleotides are clustered around the binding site of the p-site tRNA (6, 14). When the 
locations of these nucleotides were examined in context of the 3D crystal structure with 
tRNAs bound (14), all five of these nucleotides are within 10 Å of the binding site of the p-
site tRNA (Figure 5.4B-D), implying that this binding interaction caused the change in 
SHAPE reactivity.  Two of the nucleotides that increased upon Ksg addition (A1229, and 
A1339), make direct interactions with the minor groove of the p-site tRNA, while nt A1227 
is near the backbone, but slightly further away (Figure 5.4D).  Furthermore, nts U965 and 
C967, are near the anticodon loop of the P-site tRNA (Figure 5.4D).  
Since the nts that increase in SHAPE reactivity are near the P-site tRNA binding site, 
it implies that P-site tRNA is not bound or is at least bound in a distorted manner in 70S 
ribosomes from Ksg-treated cells. These data are consistent with in vitro studies showing that 
Ksg inhibits tRNA binding to the P-site (3).  If these changes in nucleotide dynamics were 
caused by bulk translation being halted and the 70S ribosomes were finishing translating, we 
would also expect to see changes in the dynamics of nucleotides that form the binding sites 
for the A-site tRNA, E-site tRNA, and mRNA.  However, changes observed for 70S 
ribosoms with Ksg bound were localized to the P-site.   
5.2.4 Ksg induces large structural changes in the 30S subunit in vivo 
In contrast to the relatively small structural effect Ksg had on the 70S, significant 
changes in the RNA structure were observed in 30S subunits from Ksg-treated cells.  When 
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no antibiotic (Ksg) was added to cells, the SHAPE data was largely consistent with the 
conventional secondary structure (Figure 5.5B).  Other than helix 28 (discussed in chapter 4), 
very few nucleotides in helices were shown to be reactive to SHAPE in vivo.  However, 
when Ksg was added to cells, nucleotides in several helices (e.g. helices 2 and 27) became 
reactive towards SHAPE (Figure 5.3A), indicating these helices were not fully formed when 
Ksg was added to cells. 
To identify nucleotides in vivo that undergo changes in dynamics in the 30S subunit 
when Ksg is added, the normalized SHAPE reactivities of the 30S with and without Ksg 
were directly compared (Figure 5.5A) and a SHAPE reactivity difference plot calculated 
(Figure 5.5B).   Nucleotides that exhibited a significant decrease in SHAPE reactivity 
(greater than -0.3 SHAPE units) upon Ksg addition are highlighted in blue.   Eleven 
nucleotides were identified in the 30S subunit that decreased in SHAPE reactivity. Eight of 
these nucleotides (nts 789-792, 1499-1502) are adjacent to the binding site of ksg observed in 
vitro (4).  These data are consistent with Ksg binding the 30S subunit in vivo.  Three of the 
nucleotides that decreased upon Ksg addition (nts 700-702) are not near the known Ksg 
binding site, although they have been implicated in IF3 binding (15).   
Surprisingly, we identified 31 nts in the 30S subunit that exhibited a significant 
increase in SHAPE reactivity (greater than 0.3 SHAPE units) upon Ksg addition to cells 
(Figure 5.5B, pink).  This was unexpected as in vitro probing experiments had only shown 
modest nucleotide protections to chemical probes when Ksg was bound (6).  These data 
imply that Ksg is causing a larger structural effect on the 30S structure in vivo than 
previously identified in vitro. 
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5.2.5 Ksg binds inactive 30S subunits in vitro, but does not recapitulate the effects 
observed in vivo 
 
 The binding of Ksg to 30S subunits in vitro has only been investigated with 
“activated” 30S subunits.  Activated 30S subunits have been heated at high Mg2+ 
concentrations (20 mM) at 42 °C, and undergo an RNA conformational change that allows 
efficient binding of tRNA (16).  As explained in Chapter 4, in vivo, the free 30S exists 
mainly in the “inactive” conformation. One hypothesis is that Ksg causes a larger structural 
effect when bound to the 30S in the “inactive”, rather than the active conformation.   
Therefore, we next evaluated the structural effects Ksg exerts on inactive 30S 
subunits in vitro by incubating Ksg with inactive 30S in vitro.  A portion of the resulting 
SHAPE reactivity profiles for the inactive 30S with and without Ksg is shown in Figure 5.B. 
Significant decreases in SHAPE reactivity were observed in the 790 loop upon Ksg addition, 
indicating that Ksg binds inactive 30S subunits in a similar manner to the active 30S.  
However, this method was not sufficient to recapitulate the in vivo results and no significant 
increases in SHAPE reactivity were observed upon Ksg incubation with inactive 30S (Figure 
5.BD). 
5.2.6 Ksg effects the structure of an immature 30S species in vivo 
In vivo, the free 30S peak of the polysome profile likely represents a mix of recycled 
30S and newly assembled 30S.  Since purified 30S subunits used for in vitro experiments are 
fully assembled, the in vivo structural changes caused by Ksg may be due to this binding 
interfering with a late step in 30S assembly and maturation.  To determine if Ksg only 
induces structural changes on an immature 30S, cells were first incubated with rifampicin for 
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20 minutes to halt transcription, and allow for immature 30S species to finish assembling into 
mature 30S subunits before Ksg was added and in vivo SHAPE initiated as before.  RNA 
from the free 30S subunit was obtained as described.  The resulting SHAPE reactivity profile 
is shown in comparison to in vivo 30S when no antibiotic was added (Figure 5.6E). 
A significant decrease in SHAPE reactivity at nts 789,790, 1499-1502 was observed 
(Figure 5.6F), consistent with Ksg binding.  Also, an additional decrease in SHAPE 
reactivity was observed at nts 700-702, similar to the result when just Ksg was added to cells.  
However, no significant increases in nucleotide flexibility were observed (Figure 5.6F).  
Because we saw Ksg binding to mature 30S, we can infer that Ksg must binds an immature 
30S subunit in vivo and likely interferes with a maturation step. 
5.2.7 Ksg likely interferes with a specific, late step in 30S maturation 
Some aminoglycoside antibiotics have been observed to inhibit 30S subunit assembly 
in E. coli by stimulating misreading leading to the accumulation of a 21S peak 
(corresponding to a protein deficient pre-30S particle) in the sucrose gradient profile (17). 
However, since the small subunit of Ksg-treated cells sedimented as a 30S peak (Figure 
5.1B) and no 21S peak was observed, it is likely that Ksg is binding to an almost fully 
assembled 30S subunit that has all or most of its ribosomal proteins bound.  
 Furthermore, if Ksg was interfering with an early step of 30S subunit assembly, then 
the nucleotides that become more flexible upon Ksg addition to cells would be expected to 
reside near late-binding proteins in the 3"-domain.  The SHAPE-identified structural changes 
that occur from Ksg binding the in vivo 30S were superimposed on the secondary structure of 
the 16S rRNA (Figure 5.6A).  Most of the nucleotides that became more flexible upon Ksg 
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addition are located in the central domain.  Therefore, it is likely that Ksg binding is 
interfering with a specific step that occurs late in the maturation of the 30S subunit. 
5.2.8 Ksg-induced structural changes are adjacent to the binding site of the 
methyltransferase KsgA 
 
 During the late stage of assembly, the 30S subunit associates with many chaperones 
and maturation factors (18).  One of the maturation factors is the universally conserved 
dimethyltransferase KsgA which methylates the two adjacent adenosines in helix 45, A1518 
and A1519 (9, 19). KsgA only recognizes a near mature 30S subunit and is necessary for 
final ribosome biogenesis (20).  Since lack of these methylations confer resistance to Ksg, it 
seems likely that one of Ksg actions in vivo is to interfere with the functions of the 
methyltransferase KsgA.  
 KsgA has been shown to interact with the nonmethylated 30S subunit extensively at 
helices h24, h27, and h45 initially through chemical probing with hydroxyl radicals (21), and 
most recently in a cryo-EM structure (22).  The sites identified by hydroxyl radical probing 
to interact directly with KsgA were superimposed on the secondary structure of the 16S 
rRNA (Figure 5.7A).  Many of the nucleotides that interact directly with KsgA are adjacent 
to nucleotides that increased in flexibility when Ksg is bound to 30S subunits. 
 The nucleotides in 30S subunits that changed in SHAPE reactivity in vivo were 
superimposed onto the three-dimensional model of the 30S in the active conformation along 
with the sites identified by chemical probing to interact directly with KsgA (Figure 5.6B).  
This model is just an approximation since it is of the active and not inactive 30S, but it is 
useful to give relative positions of where KsgA binds in relation to the experimental data.  
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The nucleotides that increase in flexibility when Ksg binds the 30S in vivo are almost all 
localized around the binding site of KsgA.  Thus, it seems likely that one of the modes of 
action of Ksg in vivo concerns the methylation step carried out by KsgA. 
5.3 Discussion 
 Here I have identified the effect Ksg exerts on the structure of the 70S ribosome and 
the free 30S subunit in vivo.  Kasugamycin seems to cause a larger RNA structural change to 
30S subunits than 70S ribosomes in vivo. When Ksg was added to cells, only a few 
nucleotides that make up the P site in the 70S became reactive towards SHAPE reagent 1M7 
(Figure 5.4A), consistent with in vitro observations that Ksg inhibits binding of the p-site 
tRNA (3). 
Conversely, Ksg seemed to exert a much stronger affect on the structure of the 30S 
subunit in vivo.   The observation that nucleotides in the 790 loop decreased significantly in 
SHAPE reactivity when Ksg was added implies that Ksg binds the in vivo 30S in its putative 
in vitro binding site (Figure 5.5A).  Surprisingly however, binding of Ksg seemed to cause a 
large disruption in the 16S rRNA structure.  Nucleotides in helices 2 and 27 became much 
more flexible, indicating those helices are not formed when Ksg is bound to the 30S in vivo 
(Figures 5.3A, 5.6A). 
5.3.1 Ksg binds the 16S rRNA in both the active and inactive conformational states. 
  In vitro SHAPE investigation of the effects of Ksg binding on 16S rRNA structure 
reveals that Ksg binds the 16S rRNA in a variety of conformational states.  Since the inactive 
conformational state of the 30S subunit forms an alternate structure in the neck region, it is 
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likely that the binding site of Ksg is distorted.  However, SHAPE analysis of both the 
inactive (Figure 5.5B) and active 30S that had been exposed to Ksg showed significant 
decreases in reactivity at the 790 loop, indicating that Ksg had bound in both cases.  Thus 
Ksg binding is fairly insensitive to distortion of its binding pocket. This implies that the 
resistance conferred to KsgA by the lack of methylations at A1518 and A1519 is not due to 
an indirect structural perturbation of the binding site. 
5.3.2 A secondary mode of action for Ksg in vivo 
 The fact that mutant ribosomes that confer resistance to Ksg in vivo are still able to 
bind Ksg in vitro strongly suggests another mode of action for Ksg in vivo.  Although Ksg 
seems to bind multiple conformations of the 30S subunit, it only induced large changes to the 
30S RNA structure in vivo (Figure 5.6A).  Moreover, these changes were no longer observed 
when transcription was halted (Figure 5.6 E,F).  This implies that Ksg acts on an almost 
mature 30S subunit. Additionally, these sites that underwent large changes are largely 
clustered around the binding site of KsgA (Figure 5.7B).  This implies that Ksg may inhibit 
some part of how KsgA works.  
 KsgA and its substrate are highly conserved throughout almost all kingdoms and is 
thought to serve a regulatory role by preventing immature 30S subunits from entering into 
the initiation phase prematurely (#CITE).  The current model for KsgA action involves two 
RNA conformational changes (Figure 5.8A)(20, 22).  KsgA binds to an almost mature 30S 
subunit, making contacts with the platform (and possibly helix44).  After an RNA 
conformational change occurs that results in orienting helix 45 near the platform, KsgA 
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methylates helix 45.  KsgA dissociates following methylation, allowing for a conformational 
rearrangement of helix 44 and the final processing of the rRNA to occur (20). 
 It is possible that Ksg is binding a very immature 30S subunit and inhibiting KsgA 
binding, however it seems an unlikely coincidence that most of the nucleotides that increase 
in flexibility in the 30S are adjacent to sites indicated to bind KsgA.  We propose that Ksg is 
interfering with one of the RNA conformational changes that occurs while KsgA is bound 
(Figure 5.7B, C).  Since nucleotides comprising helix 2 (central pseudoknot) are reactive, one 
hypothesis is that Ksg is preventing the formation of the central pseudoknot and that this is 
one of the RNA conformational changes that must occur before KsgA will methylate helix 
45. 
5.4 Experimental 
5.4.1 In-cell SHAPE 
E. coli cells (DH5α) were grown to mid-logarithmic phase (OD600 ~0.6) at 37 °C and 
then incubated with either sterile water (10% vol/vol) or antibiotic [(Rifampicin 18.75 
µg/mL, final)(Kasugamycin 10 mg/mL, final)] for 20 min. Cells (200 mL) were added to 6.2 
mL 166.67 mM 1M7 (dissolved in anhydrous DMSO [3% vol/vol], 5 mM 1M7 final).  
Concurrently, a no-reagent control was performed omitting 1M7.  Samples were allowed to 
react with shaking for 2 to 5 min at 37 °C.  The cells were rapidly chilled by pouring samples 
over 150 g of ice, and samples were spun for 20 min at 14,000 g at 4 °C in a Sorvall GSA 
rotor.  Cells were resuspended in ~1 mL lysis buffer [20 mM Hepes-KOH (pH 7.8), 0.5 mM 
MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol, 16% sucrose], lysozyme (15 µL, 50 
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mg/mL) was added, and samples were incubated on ice for 15 min.  Cell lysis was initiated 
by freezing the samples in liquid N2, followed by thawing in ice water.  The freeze-thaw 
cycle was repeated twice.  After the last cycle, the cells were incubated on ice with 10 µL 
sodium deoxycholate (15 µg/mL).  Cellular debris was removed by spinning 45 min at 
24,000 g at 4 °C.   
5.4.2 Purification of ribosomal components from SHAPE-treated cells 
Pd-10 columns (GE Healthcare) were equilibrated with buffer [20 mM Hepes-KOH 
(pH 7.8), 0.5 mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] according to the 
manufacturer’s protocol.  Sucrose sedimentation profiles were performed essentially as 
described (23).  The cleared cell lysate (~2 mL) was loaded onto columns, and columns were 
spun for 2 min at 4,000 g at 4 °C in a swinging-bucket rotor to remove the hydrolyzed 1M7.  
The lysate was then loaded onto a 10-45% sucrose gradient in polysome buffer [20 mM 
Hepes-KOH (pH 7.5), 6 mM MgCl2, 100 mM NH4Cl, 4 mM SH4] and spun in an SW28 rotor 
at 40,000 g for 12 hr at 4 °C.  The speed and time were optimized to allow resolution of both 
polysomes and 30S subunits.  Gradients were fractionated (0.5 mL per fraction) using a 
Biocomp Piston Gradient Fractionator with a BIORAD Econo UV Monitor (Abs260 scale of 
1.0).  Fractions corresponding to 30S subunits, 70S ribosomes, and polysomes (four or more 
ribosomes) were pooled and concentrated (Amicon Ultra, 100,000 MWCO, Millipore).  RNA 
was extracted using the Qiagen RNeasy Mini kits according to instructions.  RNA 
concentration was determined by absorbance at 260 nM. 
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5.4.3 In vitro SHAPE modification 
Escherichia coli DH4α 30S subunits were purified as described (24).  Inactivation 
and reactivation of 30S subunits was done essentially as described (25).  For inactivation, 
30S subunits were incubated at 4 °C in inactivation buffer [20 mM Hepes-KOH (pH 7.5), 0.5 
mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] for 20 min and then at 15 °C for 15 
min.  For activation, 30S subunits were incubated in activation buffer [20 mM Hepes-KOH 
(pH 7.5), 20 mM MgCl2, 100 mM NH4Cl, 4 mM β-mercaptoethanol] for 20 min at 42 °C.  
Buffer was added to lower the concentration of magnesium chloride to 10 mM, and subunits 
incubated at 15 °C for 15 min. Kasugamycin (0.5 mM final) or sterile water was added, and 
samples were incubated at 15 °C for 20 min.  After incubation, 45 µL of the 30S subunit 
sample (with or without kasugamycin treatment) was added to 5 µL 50 mM 1M7 (in 
anhydrous DMSO) and incubated at 15 °C for 10 min.  No reagent control reactions were 
performed by addition of 5 µL neat DMSO.  RNA was extracted using the Qiagen RNeasy 
Mini kits according to the manufacturer’s instructions.  RNA concentration was determined 
by absorbance at 260 nM. 
5.4.4 Primer extension 
 Five primers of 19-22 nucleotides were used for analysis of 16S rRNA. The 3" 
positions of the primers were complementary to 16S rRNA positions 323, 559, 947, 1112, 
and 1492 (26). The DNA primers were 5"-end labeled with either VIC or NED fluorophores 
(Applied Biosystems).  The VIC-labeled primer was used for the (+) or (–) 1M7 channel.  
The NED-labeled primer was used for the sequencing channel. A sixth 5"-[32P]-labeled DNA 
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primer complementary to 1542 [20 µL; 70 mM Tris-HCl, 10 mM MgCl2, 5 mM 
dithiothreitol, 1 µL T4 polynucleotide kinase (PNK, 10,000 units/mL), 16 µCi [γ-32P]-ATP; 
37 °C; 30min] was used to analyze the 3" end of the 16S rRNA.  The radiolabeled DNA 
primer was purified by gel electrophoresis (20% polyacrylamide, 29:1 
acrylamid:bisacrylamide, 0.4 mM x 28.5 cm x 23 cm; 45 W; 1hr), excised from the gel and 
recovered by overnight passive elution at 4 °C into 250 µL TE (10 mM Tris-HCl, pH 8.0, 1 
mM EDTA) and separated from solid acrylamide by microfiltration (EZ spin columns, 
Millipore). 
 The modified RNA (1.5 pmol) and primer (2 pmol) were mixed and diluted to 13 µL 
with H2O.  The primers were allowed to anneal for 6 min at 65 °C, and then samples were 
cooled on ice.  Reverse transcription buffer [6 µL; 167 mM Tris-HCl (pH 8.3), 250 mM KCl, 
10 mM MgCl2, 1.67 mM each dNTP] and Superscript III (1 µL, 200 units) were added, and 
samples were incubated at 45 °C for 2 min, 52 °C for 60 min, then 65 °C for 5 min.  The 
reactions were quenched with 4 µL 50 mM EDTA.  The cDNAs were recovered by ethanol 
precipitation, washed twice with 70% ethanol, dried at 65 °C for 5 min, and resuspended in 
10 µL deionized formamide.   
Dideoxy sequencing ladders were produced using unlabeled, unmodified total cellular 
RNA (0.5 mM).  2",3"-dideoxycytidine triphosphate (1 µL of 5 mM) was added before 
addition of Superscript III. cDNA fragments were separated by capillary electrophoresis 
using the Applied Biosystems 3500 DNA sequencing instrument.  The radiolabeled cDNA 
products were resolved by gel electrophoresis (10% polyacrylamide, 29:1 
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acrylamide:bisacrylamide, 0.4 cm x 31 cm x 38.5 cm; 70W; 2hr); and visualized by 
phosphorimaging. 
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Figure 5.1.  Addition of Ksg leads to depletion of polysomes but not accumulation of 
protein-deficient particles in vivo. Ribosome sedimentation profiles of E. coli DH5α 
obtained (A) in the absence of Ksg and (B) presence of Ksg.  
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Figure 5.2. In vivo SHAPE analysis of  Ksg bound to 70S ribosomes.  In vivo absolute 2"-
hydroxyl reactivities superimposed on the E. coli 16S resulting from 70S ribosomes when 
(A) Ksg was added to cells (B) or when no antibiotic was added 
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Figure 5.3. In vivo SHAPE analysis of  Ksg bound to 30S subunits.  In vivo absolute 2"-
hydroxyl reactivities superimposed on the E. coli 16S resulting from 30S subunits when (A) 
Ksg was added to cells (B) or when no antibiotic was added 
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Figure 5.4. Effects of Ksg binding 70S ribosome are localized to the P-site. (A) 
Histograms comparing absolute SHAPE reactivities of 70S ribosomes isolated from cells 
grown without antibiotic (black) to cells grown with Ksg (yellow). (B) Nucleotides in the 
70S ribosome identified to increase significantly (greater than 0.3 SHAPE units) upon Ksg 
addition to cells (red) and nucleotides that are within 10 Å of the P-site tRNA (orange) are 
highlighted on (B) the model of the E. coli secondary structure (C) the crystal structure. The 
P-site tRNA is shown in yellow. (D) Same as C, but zoomed in and turned slightly. 
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Figure 5.5. SHAPE-identified effects of Ksg on the 30S subunit in three states. 
Histograms comparing absolute SHAPE reactivities of 30S ribosomes in the absence and 
presence of Ksg (A) 30S subunits modified in vivo with Ksg present (magenta) or absent 
(grey) (B) In vitro 30S ribosomes in the inactive conformation incubated with Ksg (cyan) or 
without Ksg (black)  (C) 30S subunits modified in vivo when transcription had first been 
turned off with Rif, and then Ksg was added (purple) or when no antibiotic was added (grey).  
SHAPE reactivity difference plots for each comparison are shown directly underneath the 
historgrams.  Nucleotides that changed significantly in SHAPE reactivity (more than 0.3 
SHAPE units) are highlighted by colored bars as described. 
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Figure 5.6. Kasugamycin induced structural changes in the in vivo 30S subunit are 
located near the binding sit of KsgA. Nucleotides that were identified by in vivo SHAPE to 
undergo significant changes in local nucleotide dynamics when Ksg is bound to 30S subunits 
and nucleotides implicated in KsgA binding by hydroxyl radical probing ((27)) are shown on 
the (A) secondary structure of the 16S rRNA (B) and three-demonsional structure of 30S 
subunits bound by Ksg (PDB file 1VS5; (4) ). (C) A zoomed-in and slightly rotated view.  
Nucleotides that became less or more flexible upon Ksg binding are colored blue and 
magenta, respectively, and are shown in stick representation. Directed hydroxyl radica 
cleavage (green) and footprinting sites (cyan) are shown by an exagerated backbone.  The 
methylated adenosine residues are highlighted in black with black spheres at the N6 position.  
Ksg is shown in a space-fill representation.  
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Figure 5.7.  Working models of ksg inhibition of small subunit biogenesis. (A) Cartoon of 
conformational rearrangements controlled by KsgA. (B,C) Models for how Ksg ight interfere 
with KsgA 
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